"Drug Name","Active Ingredient","Form; Route","Appl. No.","Company","Date","URL"
"ABACAVIR and LAMIVUDINE","ABACAVIR SULFATE;LAMIVUDINE","TABLET;ORAL","204311","MYLAN LABORATORIES LIMITED","12/22/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34"
"ABILIFY","ARIPIPRAZOLE","SOLUTION;ORAL","021713","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"ABILIFY","ARIPIPRAZOLE","TABLET, ORALLY DISINTEGRATING;ORAL","021729","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"ABILIFY","ARIPIPRAZOLE","TABLET;ORAL","021436","OTSUKA","11/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47"
"ABILIFY","ARIPIPRAZOLE","INJECTABLE;INTRAMUSCULAR","021866","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"ABILIFY MAINTENA KIT","ARIPIPRAZOLE","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","202971","OTSUKA PHARM CO LTD","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52"
"ABILIFY MYCITE KIT","ARIPIPRAZOLE","TABLET;ORAL","207202","OTSUKA","11/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf#page=64"
"ABRILADA","ADALIMUMAB-AFZB","INJECTABLE;INJECTION","761118","PFIZER INC","10/04/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47"
"ABSORICA","ISOTRETINOIN","CAPSULE;ORAL","021951","SUN PHARM INDS INC","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32"
"ABSTRAL","FENTANYL CITRATE","TABLET;SUBLINGUAL","022510","SENTYNL THERAPS INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29"
"ACCUTANE","ISOTRETINOIN","CAPSULE;ORAL","018662","HOFFMANN LA ROCHE","10/22/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf"
"ACIPHEX","RABEPRAZOLE SODIUM","TABLET, DELAYED RELEASE;ORAL","020973","WOODWARD","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34"
"ACIPHEX SPRINKLE","RABEPRAZOLE SODIUM","CAPSULE, DELAYED RELEASE;ORAL","204736","AYTU","11/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21"
"ACTEMRA","TOCILIZUMAB","INJECTABLE; INJECTION","125276","GENENTECH","09/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55"
"ACTEMRA","TOCILIZUMAB","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","125472","GENENTECH","09/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55"
"ACTHAR GEL","CORTICOTROPIN","INJECTABLE;INJECTION","008372","MALLINCKRODT ARD","02/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf#page=17"
"ACTIQ","FENTANYL CITRATE","TROCHE/LOZENGE;TRANSMUCOSAL","020747","CEPHALON","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44"
"ACTONEL","RISEDRONATE SODIUM","TABLET;ORAL","020835","APIL","11/05/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38"
"ACTONEL WITH CALCIUM (COPACKAGED)","CALCIUM CARBONATE; RISEDRONATE SODIUM","TABLET;ORAL","021823","WARNER CHILCOTT","04/08/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27"
"ACTOPLUS MET","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TABLET;ORAL","021842","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41"
"ACTOPLUS MET XR","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","022024","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41"
"ACTOS","PIOGLITAZONE HYDROCHLORIDE","TABLET;ORAL","021073","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35"
"ADASUVE","LOXAPINE","POWDER;INHALATION","022549","ALEXZA PHARMS","02/01/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28"
"ADDERALL 10","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"
"ADDERALL 12.5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"
"ADDERALL 15","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"
"ADDERALL 20","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15"
"ADDERALL 30","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","02/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"
"ADDERALL 5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","02/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"
"ADDERALL 7.5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","TABLET;ORAL","011522","TEVA WOMENS","02/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15"
"ADDERALL XR 10","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"
"ADDERALL XR 15","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"
"ADDERALL XR 20","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"
"ADDERALL XR 25","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22"
"ADDERALL XR 30","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"ADDERALL XR 5","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"ADDYI","FLIBANSERIN","TABLET;ORAL","022526","SPROUT PHARMS","09/29/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23"
"ADEMPAS","RIOCIGUAT","TABLET;ORAL","204819","BAYER HLTHCARE","09/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24"
"ADHANSIA XR","METHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","212038","PURDUE PHARMA LP","06/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25"
"ADLYXIN","LIXISENATIDE","SOLUTION;SUBCUTANEOUS","208471","SANOFI-AVENTIS US","09/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208471s007lbl.pdf#page=24"
"ADUHELM","ADUCANUMAB-AVWA","INJECTABLE; INJECTION","761178","BIOGEN INC","08/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26"
"ADZENYS ER","AMPHETAMINE","SUSPENSION, EXTENDED RELEASE;ORAL","204325","NEOS THERAPS INC","02/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26"
"ADZENYS XR-ODT","AMPHETAMINE","TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL","204326","NEOS THERAPS","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204326s011lbl.pdf#page=27"
"AFREZZA","INSULIN RECOMBINANT HUMAN","POWDER;INHALATION","022472","MANNKIND","02/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022472s023lbl.pdf#page=19"
"ALKINDI SPRINKLE","Hydrocortisone","GRANULE;ORAL","213876","ETON","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14"
"ALVAIZ","ELTROMBOPAG CHOLINE","TABLET;ORAL","216677","TEVA PHARMACEUTICALS","11/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30"
"AMBIEN","ZOLPIDEM TARTRATE","TABLET;ORAL","019908","SANOFI AVENTIS US","02/23/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24"
"AMBIEN CR","ZOLPIDEM TARTRATE","TABLET, EXTENDED RELEASE;ORAL","021774","SANOFI AVENTIS US","02/23/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27"
"AMJEVITA","ADALIMUMAB-ATTO","INJECTABLE;INJECTION","761024","AMGEN INC","08/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761024s015lbl.pdf#page=50"
"AMPYRA","DALFAMPRIDINE","TABLET, EXTENDED RELEASE;ORAL","022250","ACORDA","11/18/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13"
"ANAFRANIL","CLOMIPRAMINE HYDROCHLORIDE","CAPSULE;ORAL","019906","SPECGX LLC","05/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27"
"ANAPROX","NAPROXEN SODIUM","TABLET;ORAL","018164","ATNAHS PHARMA US","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
"ANAPROX DS","NAPROXEN SODIUM","TABLET;ORAL","018164","ATNAHS PHARMA US","05/13/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23"
"ANDROGEL","TESTOSTERONE","GEL, METERED;TRANSDERMAL","022309","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25"
"ANDROGEL","TESTOSTERONE","GEL;TRANSDERMAL","022309","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25"
"ANDROGEL","TESTOSTERONE","GEL;TRANSDERMAL","021015","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23"
"ANDROGEL","TESTOSTERONE","GEL, METERED;TRANSDERMAL","021015","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23"
"ANSAID","FLURBIPROFEN","TABLET;ORAL","018766","PHARMACIA AND UPJOHN","05/09/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf"
"APADAZ","ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE","TABLET;ORAL","208653","KVK TECH INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40"
"APLENZIN","BUPROPION HYDROBROMIDE","TABLET, EXTENDED RELEASE;ORAL","022108","BAUSCH","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf#page=29"
"APTENSIO XR","METHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","205831","RHODES PHARMS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205831s008lbl.pdf#page=19"
"APTIOM","ESLICARBAZEPINE ACETATE","TABLET;ORAL","022416","SUNOVION PHARMS INC","03/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25"
"APTRYXOL","DESVENLAFAXINE","TABLET,EXTENDED RELEASE;ORAL","205583","SUN PHARMACEUTICAL","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30"
"ARANESP","DARBEPOETIN ALFA","VIAL; INTRAVENOUS","103951","AMGEN","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25"
"ARANESP","DARBEPOETIN ALFA","VIAL; SUBCUTANEOUS","103951","AMGEN","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25"
"ARCAPTA NEOHALER","INDACATEROL MALEATE","POWDER;INHALATION","022383","NOVARTIS","07/30/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf"
"ARIKAYCE KIT","AMIKACIN SULFATE","SUSPENSION, LIPOSOMAL;INHALATION","207356","INSMED INC","02/10/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15"
"ARISTADA","ARIPIPRAZOLE LAUROXIL","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","207533","ALKERMES INC","03/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36"
"ARISTADA INITIO KIT","ARIPIPRAZOLE LAUROXIL","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","209830","ALKERMES INC","03/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72"
"ARTHROTEC","DICLOFENAC SODIUM; MISOPROSTOL","TABLET, DELAYED RELEASE;ORAL","020607","PFIZER","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33"
"ARYMO ER","MORPHINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","208603","ZYLA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34"
"ASTAGRAF XL","TACROLIMUS","CAPSULE, EXTENDED RELEASE;ORAL","050709","ASTELLAS","11/22/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91"
"ASTAGRAF XL","TACROLIMUS","CAPSULE, EXTENDED RELEASE;ORAL","050708","ASTELLAS","09/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91"
"ASTAGRAF XL","TACROLIMUS","CAPSULE, EXTENDED RELEASE;ORAL","210115","ASTELLAS","09/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33"
"ASTAGRAF XL","TACROLIMUS","CAPSULE, EXTENDED RELEASE;ORAL","204096","ASTELLAS","09/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33"
"ATELVIA","RISEDRONATE SODIUM","TABLET, DELAYED RELEASE;ORAL","022560","APIL","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24"
"ATIVAN","LORAZEPAM","TABLET;ORAL","017794","BAUSCH","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14"
"AUBAGIO","TERIFLUNOMIDE","TABLET;ORAL","202992","SANOFI AVENTIS US","06/10/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25"
"AUSTEDO","DEUTETRABENAZINE","TABLET;ORAL","216354","TEVA NEUROSCIENCE","05/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf#page=29"
"AUSTEDO","DEUTETRABENAZINE","TABLET;ORAL","208082","TEVA BRANDED PHARM","11/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208082s016s017lbl.pdf#page=29"
"AUVELITY","BUPROPION; DEXTROMETHORPHAN","TABLET, EXTENDED RELEASE; ORAL","215430","AXSOME INC","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf#page=25"
"AVANDAMET","METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE","TABLET;ORAL","021410","SB PHARMCO","04/05/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38"
"AVANDARYL","GLIMEPIRIDE; ROSIGLITAZONE MALEATE","TABLET;ORAL","021700","SB PHARMCO","04/27/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39"
"AVANDIA","ROSIGLITAZONE MALEATE","TABLET;ORAL","021071","WOODWARD","02/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38"
"AVEED","TESTOSTERONE UNDECANOATE","INJECTABLE;INTRAMUSCULAR","022219","ENDO PHARMS INC","08/16/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23"
"AVELOX","MOXIFLOXACIN HYDROCHLORIDE","TABLET;ORAL","021085","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
"AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER","MOXIFLOXACIN HYDROCHLORIDE","SOLUTION;INTRAVENOUS","021277","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
"AVINZA","MORPHINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","021260","KING PHARMS LLC","06/26/2015","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf"
"AVONEX","INTERFERON BETA-1A","VIAL","103628","BIOGEN","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22"
"AVSOLA","INFLIXIMAB-AXXQ","INJECTABLE;INJECTION","761086","AMGEN INC","09/09/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48"
"AXIRON","TESTOSTERONE","SOLUTION, METERED;TRANSDERMAL","022504","ELI LILLY AND CO","07/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15"
"AZSTARYS","DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE","CAPSULE;ORAL","212994","COMMAVE THERAP","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26"
"BANZEL","RUFINAMIDE","SUSPENSION;ORAL","201367","EISAI INC","05/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19"
"BANZEL","RUFINAMIDE","TABLET;ORAL","021911","EISAI INC","11/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19"
"BAVENCIO","AVELUMAB","INJECTABLE;INJECTION","761049","EMD SERONO INC","11/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761049s020lbl.pdf#page=36"
"BAVENCIO","AVELUMAB","INJECTABLE;INTRAVENOUS","761078","EMD SERONO INC","05/09/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23"
"BAXDELA","DELAFLOXACIN MEGLUMINE","TABLET;ORAL","208610","MELINTA","06/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28"
"BAXDELA","DELAFLOXACIN MEGLUMINE","POWDER;INTRAVENOUS","208611","MELINTA","12/01/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28"
"BELBUCA","BUPRENORPHINE HYDROCHLORIDE","FILM;BUCCAL","207932","BDSI","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40"
"BELSOMRA","SUVOREXANT","TABLET;ORAL","204569","MERCK SHARP DOHME","03/25/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23"
"BENLYSTA","BELIMUMAB","INJECTABLE;INJECTION","761043","GLAXOSMITHKLINE LLC","05/16/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41"
"BENLYSTA","BELIMUMAB","INJECTABLE; INJECTION","125370","HUMAN GENOME SCIENCES INC.","05/16/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41"
"BESREMI","ROPEGINTERFERON ALFA-2B-NJFT","INJECTABLE;SUBCUTANEOUS","761166","PHARMAESSENTIA CORP","04/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf#page=18"
"BETASERON","INTERFERON BETA-1B","VIAL; SUBCUTANEOUS","103471","BAYER HEALTHCARE PHARMS","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19"
"BEVYXXA","BETRIXABAN","CAPSULE;ORAL","208383","PORTOLA PHARMS INC","08/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20"
"BIMZELX","BIMEKIZUMAB-BKZX","INJECTABLE; SUBCUTANEOUS","761151","UCB INC","09/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29"
"BINOSTO","ALENDRONATE SODIUM","TABLET, EFFERVESCENT;ORAL","202344","ASCEND THERAPS US","10/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33"
"BLENREP","BELANTAMAB MAFODOTIN-BLMF","INJECTABLE;INTRAVENOUS","761158","GLAXOSMITHKLINE","02/28/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22"
"BLINCYTO","BLINATUMOMAB","INJECTABLE;INJECTION","125557","AMGEN","06/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41"
"BONIVA","IBANDRONATE SODIUM","INJECTABLE;INTRAVENOUS","021858","ROCHE","01/11/2022","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18"
"BONIVA","IBANDRONATE SODIUM","TABLET;ORAL","021455","HOFFMANN LA ROCHE","12/07/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19"
"BONSITY","TERIPARATIDE","SOLUTION;SUBCUTANEOUS","211939","ALVOGEN","11/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211939s004lbl.pdf#page=23"
"BOTOX","OnabotulinumtoxinA","VIAL; SINGLE-USE","103000","ALLERGAN","08/10/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49"
"BOTOX COSMETIC","OnabotulinumtoxinA","VIAL; SINGLE-USE","103000","ALLERGAN","08/10/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49"
"BRAFTOVI","ENCORAFENIB","CAPSULE;ORAL","210496","ARRAY BIOPHARMA INC","09/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s016lbl.pdf#page=31"
"BRENZAVVY","BEXAGLIFLOZIN","TABLET;ORAL","214373","THERACOS BIO","09/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22"
"BREXAFEMME","IBREXAFUNGERP","TABLET;ORAL","214900","SCYNEXIS","11/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf#page=18"
"BRILINTA","TICAGRELOR","TABLET;ORAL","022433","ASTRAZENECA","03/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35"
"BRISDELLE","PAROXETINE MESYLATE","CAPSULE;ORAL","204516","SEBELA IRELAND LTD","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204516s013lbl.pdf#page=18"
"BRIUMVI","UBLITUXIMAB-XIIY","INJECTABLE;INJECTION","761238","TG Therapeutics","12/28/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf#page=18"
"BRIVIACT","BRIVARACETAM","SOLUTION;INTRAVENOUS","205837","UCB INC","05/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
"BRIVIACT","BRIVARACETAM","SOLUTION;ORAL","205838","UCB INC","05/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
"BRIVIACT","BRIVARACETAM","TABLET;ORAL","205836","UCB INC","05/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
"BRIXADI","BUPRENORPHINE","INJECTION, EXTENDED RELEASE;SUBCUTANEOUS","210136","BRAEBURN","05/23/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52"
"BROVANA","ARFORMOTEROL TARTRATE","SOLUTION;INHALATION","021912","SUNOVION","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22"
"BUNAVAIL","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","FILM;BUCCAL","205637","BDSI","06/17/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33"
"BUTRANS","BUPRENORPHINE","FILM, EXTENDED RELEASE;TRANSDERMAL","021306","PURDUE PHARMA LP","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45"
"BYDUREON","EXENATIDE SYNTHETIC","FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","022200","ASTRAZENECA AB","12/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37"
"BYDUREON BCISE","EXENATIDE SYNTHETIC","SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","209210","ASTRAZENECA AB","03/06/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf#page=36"
"BYDUREON PEN","EXENATIDE SYNTHETIC","FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","022200","ASTRAZENECA AB","12/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37"
"BYETTA","EXENATIDE SYNTHETIC","INJECTABLE;SUBCUTANEOUS","021773","ASTRAZENECA AB","12/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf#page=33"
"BYETTA","EXENATIDE SYNTHETIC","INJECTABLE; SUBCUTANEOUS","021919","AMYLIN","10/30/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf"
"CAMBIA","DICLOFENAC POTASSIUM","FOR SOLUTION;ORAL","022165","ASSERTIO","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22"
"CAMZYOS","MAVACAMTEN","CAPSULE;ORAL","214998","BRISTOL MYERS SQUIBB","06/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29"
"CAPLYTA","LUMATEPERONE TOSYLATE","CAPSULE;ORAL","209500","INTRA-CELLULAR","06/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209500s011lbl.pdf#page=22"
"CAPRELSA","VANDETANIB","TABLET;ORAL","022405","GENZYME CORP","03/28/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf#page=20"
"CARBATROL","CARBAMAZEPINE","CAPSULE, EXTENDED RELEASE;ORAL","020712","TAKEDA PHARMS USA","04/11/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23"
"CASSIPA","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","FILM;SUBLINGUAL","208042","TEVA PHARMS USA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30"
"CATAFLAM","DICLOFENAC POTASSIUM","TABLET;ORAL","020142","NOVARTIS","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19"
"CELEBREX","CELECOXIB","CAPSULE;ORAL","020998","UPJOHN","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41"
"CELEBREX","CELECOXIB","CAPSULE;ORAL","021156","GD SEARLE LLC","02/04/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf"
"CELEXA","CITALOPRAM HYDROBROMIDE","SOLUTION;ORAL","021046","FOREST LABS","12/03/2012","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32"
"CELEXA","CITALOPRAM HYDROBROMIDE","TABLET;ORAL","020822","ALLERGAN","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22"
"CELLCEPT","MYCOPHENOLATE MOFETIL","CAPSULE;ORAL","050722","ROCHE PALO","08/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
"CELLCEPT","MYCOPHENOLATE MOFETIL","TABLET;ORAL","050723","ROCHE PALO","08/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
"CELLCEPT","MYCOPHENOLATE MOFETIL HYDROCHLORIDE","INJECTABLE;INJECTION","050758","ROCHE PALO","08/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
"CELLCEPT","MYCOPHENOLATE MOFETIL","FOR SUSPENSION;ORAL","050759","ROCHE PALO","08/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
"CELONTIN","METHSUXIMIDE","CAPSULE;ORAL","010596","PARKE DAVIS","06/15/2011","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf"
"CERDELGA","ELIGLUSTAT TARTRATE","CAPSULE;ORAL","205494","GENZYME CORP","08/29/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19"
"CHANTIX","VARENICLINE TARTRATE","TABLET;ORAL","021928","PF PRISM CV","02/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22"
"CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE","AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE","TABLET;ORAL","071297","MYLAN PHARMS INC","02/05/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf"
"CIBINQO","ABROCITINIB","TABLET; ORAL","213871","PFIZER INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf#page=27"
"CIMZIA","CERTOLIZUMAB PEGOL","INJECTABLE; INJECTION","125160","UCB INC","09/13/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125160s275lbl.pdf#page=42"
"CIPRO","CIPROFLOXACIN HYDROCHLORIDE","TABLET;ORAL","019537","BAYER HLTHCARE","09/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"
"CIPRO","CIPROFLOXACIN","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","03/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33"
"CIPRO","CIPROFLOXACIN","FOR SUSPENSION;ORAL","020780","BAYER HLTHCARE","09/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"
"CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER","CIPROFLOXACIN","INJECTABLE;INJECTION","019857","BAYER HLTHCARE","03/25/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33"
"CIPRO XR","CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021473","BAYER HLTHCARE","03/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30"
"CITALOPRAM","CITALOPRAM HYDROBROMIDE","CAPSULE; ORAL","215428","ALMATICA","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24"
"CLENPIQ","CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE","SOLUTION;ORAL","209589","FERRING PHARMS INC","08/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14"
"CLINORIL","SULINDAC","TABLET;ORAL","017911","MERCK","12/23/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf"
"CODEINE SULFATE","CODEINE SULFATE","SOLUTION;ORAL","202245","HIKMA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30"
"CODEINE SULFATE","CODEINE SULFATE","TABLET;ORAL","022402","HIKMA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29"
"COLCRYS","COLCHICINE","TABLET;ORAL","022352","TAKEDA PHARMS USA","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25"
"COLCRYS","COLCHICINE","TABLET; ORAL","022353","AR HOLDING CO INC","10/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19"
"COLUMVI","GLOFITAMAB-GXBM","INJECTABLE;INTRAVENOUS","761309","GENETECH","06/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf#page=19"
"COMBOGESIC","ACETAMINOPHEN; IBUPROFEN","TABLET;ORAL","209471","AFT Pharmaceuticals","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28"
"COMBUNOX","IBUPROFEN; OXYCODONE HYDROCHLORIDE","TABLET;ORAL","021378","FOREST LABS","09/02/2010","https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30"
"CONCERTA","METHYLPHENIDATE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021121","JANSSEN PHARMS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf#page=30"
"CONSENSI","AMLODIPINE BESYLATE; CELECOXIB","TABLET;ORAL","210045","PURPLE BIOTECH","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10"
"CONTRAVE","BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","200063","NALPROPION","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200063s021lbl.pdf#page=40"
"CONZIP","TRAMADOL HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","022370","CIPHER PHARMS INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37"
"COPEGUS","RIBAVIRIN","TABLET;ORAL","021511","ROCHE","08/11/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27"
"COPIKTRA","DUVELISIB","CAPSULE;ORAL","211155","SECURA","12/17/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28"
"CORDARONE","AMIODARONE HYDROCHLORIDE","TABLET;ORAL","018972","WYETH PHARMS","10/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13"
"CORLANOR","IVABRADINE HYDROCHLORIDE","TABLET;ORAL","206143","AMGEN INC","08/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"
"CORLANOR","IVABRADINE","SOLUTION;ORAL","209964","AMGEN INC","08/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"
"COSENTYX","SECUKINUMAB","INJECTABLE;SUBCUTANEOUS, INTRAVENOUS","761349","NOVARTIS PHARMACEUTICALS CORPORATION","10/06/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761349s000lbl.pdf#page=32"
"COSENTYX","SECUKINUMAB","INJECTABLE;INJECTION","125504","NOVARTIS PHARMS CORP","08/16/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125504s082lbl.pdf#page=33"
"COTEMPLA XR-ODT","METHYLPHENIDATE","TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL","205489","NEOS THERAPS INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf##page=24"
"COUMADIN","WARFARIN SODIUM","INJECTABLE;INJECTION","009218","BRISTOL MYERS SQUIBB","08/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30"
"COUMADIN","WARFARIN SODIUM","TABLET;ORAL","009218","BRISTOL MYERS SQUIBB","08/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30"
"COXANTO","OXAPROZIN","CAPSULE;ORAL","217927","SOLUBIOMIX","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24"
"CREON","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","CAPSULE, DELAYED RELEASE;ORAL","020725","ABBVIE","06/02/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16"
"CYLTEZO","ADALIMUMAB-ADBM","INJECTABLE;INJECTION","761058","BOEHRINGER INGELHEIM","04/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf#page=38"
"CYMBALTA","DULOXETINE HYDROCHLORIDE","CAPSULE, DELAYED REL PELLETS;ORAL","021427","LILLY","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38"
"DALIRESP","ROFLUMILAST","TABLET;ORAL","022522","ASTRAZENECA","01/23/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17"
"DALMANE","FLURAZEPAM HYDROCHLORIDE","CAPSULE;ORAL","016721","VALEANT PHARM INTL","03/27/2009","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf"
"DARVOCET-N 100","ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE","TABLET;ORAL","017122","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"
"DARVOCET-N 50","ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE","TABLET;ORAL","017122","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"
"DARVON","PROPOXYPHENE HYDROCHLORIDE","CAPSULE;ORAL","010997","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"
"DARVON-N","PROPOXYPHENE NAPSYLATE","TABLET;ORAL","016862","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"
"DAURISMO","GLASDEGIB MALEATE","TABLET;ORAL","210656","PFIZER","03/27/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20"
"DAXXIFY","daxibotulinumtoxinA-lanm","INJECTABLE;INTRAMUSCULAR","761127","REVANCE THERAPEUTICS, INC","08/11/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16"
"DAYPRO","OXAPROZIN","TABLET;ORAL","018841","PFIZER","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25"
"DAYPRO ALTA","OXAPROZIN POTASSIUM","TABLET;ORAL","020776","PFIZER","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22"
"DAYTRANA","METHYLPHENIDATE","SYSTEM;TRANSDERMAL","021514","NOVEN PHARMACEUTICALS, INC","11/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24"
"DAYTRANA","METHYLPHENIDATE","FILM, EXTENDED RELEASE;TRANSDERMAL","021514","NOVEN PHARMS INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021514s036lbl.pdf#page=25"
"DAYVIGO","LEMBOREXANT","TABLET;ORAL","212028","EISAI INC","04/20/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf#page=22"
"DEMEROL","MEPERIDINE HYDROCHLORIDE","TABLET;ORAL","005010","VALIDUS PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31"
"DEMEROL","MEPERIDINE HYDROCHLORIDE","INJECTABLE;INJECTION","005010","VALIDUS PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31"
"DEMEROL","MEPERIDINE HYDROCHLORIDE","SYRUP;ORAL","005010","VALIDUS PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31"
"DEPAKENE","VALPROIC ACID","CAPSULE;ORAL","018081","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41"
"DEPAKENE","VALPROIC ACID","SYRUP;ORAL","018082","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38"
"DEPAKOTE","DIVALPROEX SODIUM","CAPSULE, DELAYED REL PELLETS;ORAL","019680","ABBVIE","03/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf#page=42"
"DEPAKOTE","DIVALPROEX SODIUM","TABLET, DELAYED RELEASE;ORAL","018723","ABBVIE","03/18/2024","http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s066lbledt.pdf#page=48"
"DEPAKOTE ER","DIVALPROEX SODIUM","TABLET, EXTENDED RELEASE;ORAL","021168","ABBVIE","03/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021168s044lbl.pdf#page=48"
"DESCOVY","EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","TABLET;ORAL","208215","GILEAD SCIENCES INC","01/07/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37"
"DESOXYN","METHAMPHETAMINE HYDROCHLORIDE","TABLET;ORAL","005378","RECORDATI RARE","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12"
"DESOXYN","METHAMPHETAMINE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","005378","RECORDATI RARE","09/24/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17"
"DESVENLAFAXINE","DESVENLAFAXINE FUMARATE","TABLET, EXTENDED RELEASE;ORAL","205208","TEVA PHARMS USA","07/18/2014","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23"
"DESVENLAFAXINE","DESVENLAFAXINE","TABLET, EXTENDED RELEASE;ORAL","204150","ALEMBIC PHARMS LTD","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33"
"DESYREL","TRAZODONE HYDROCHLORIDE","TABLET;ORAL","018207","PRAGMA","10/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13"
"DESYREL","TRAZODONE HYDROCHLORIDE","TABLET;ORAL","018207","PRAGMA","10/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14"
"DEXEDRINE","DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","017078","IMPAX LABS INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf#page=14"
"DEXILANT","DEXLANSOPRAZOLE","CAPSULE, DELAYED RELEASE;ORAL","022287","TAKEDA PHARMS USA","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24"
"DEXTROAMPHETAMINE SULFATE","DEXTROAMPHETAMINE SULFATE","SOLUTION;ORAL","040776","OUTLOOK PHARMS","01/04/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7"
"DIACOMIT","STIRIPENTOL","CAPSULE;ORAL","206709","BIOCODEX SA","08/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
"DIACOMIT","STIRIPENTOL","FOR SUSPENSION;ORAL","207223","BIOCODEX SA","08/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
"DILANTIN","PHENYTOIN SODIUM","CAPSULE;ORAL","084349","UPJOHN","09/07/2022","http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21"
"DILANTIN","PHENYTOIN","TABLET, CHEWABLE;ORAL","084427","PHARMACIA","10/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17"
"DILANTIN-125","PHENYTOIN","SUSPENSION;ORAL","008762","UPJOHN","03/03/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19"
"DILANTIN-30","PHENYTOIN","SUSPENSION;ORAL","008762","UPJOHN","03/03/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19"
"DILAUDID","HYDROMORPHONE HYDROCHLORIDE","SOLUTION;ORAL","019891","RHODES PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32"
"DILAUDID","HYDROMORPHONE HYDROCHLORIDE","TABLET;ORAL","019892","RHODES PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32"
"DOLOPHINE HYDROCHLORIDE","METHADONE HYDROCHLORIDE","SYRUP;ORAL","006134","HIKMA","06/02/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36"
"DOLOPHINE HYDROCHLORIDE","METHADONE HYDROCHLORIDE","TABLET;ORAL","006134","HIKMA","06/02/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36"
"DORAL","QUAZEPAM","TABLET;ORAL","018708","GALT PHARMS","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11"
"DOTAREM","GADOTERATE MEGLUMINE","SOLUTION;INTRAVENOUS","204781","GUERBET","01/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17"
"DRIZALMA SPRINKLE","DULOXETINE HYDROCHLORIDE","CAPSULE, DELAYED REL PELLETS;ORAL","212516","SUN PHARMA GLOBAL","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45"
"DROXIA","HYDROXYUREA","CAPSULE;ORAL","016295","BRISTOL MYERS SQUIBB","11/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16"
"DUETACT","GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE","TABLET;ORAL","021925","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39"
"DUEXIS","FAMOTIDINE; IBUPROFEN","TABLET;ORAL","022519","HORIZON","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25"
"DURAGESIC-100","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DURAGESIC-12","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DURAGESIC-25","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DURAGESIC-37","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DURAGESIC-50","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DURAGESIC-75","FENTANYL","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52"
"DUZALLO","ALLOPURINOL; LESINURAD","TABLET;ORAL","209203","IRONWOOD PHARMS INC","08/18/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27"
"DYANAVEL XR","AMPHETAMINE","SUSPENSION, EXTENDED RELEASE;ORAL","208147","TRIS PHARMA INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
"DYANAVEL XR 10","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","210526","TRIS PHARMA INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
"DYANAVEL XR 15","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","210526","TRIS PHARMA INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
"DYANAVEL XR 20","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","210526","TRIS PHARMA INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
"DYANAVEL XR 5","AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","210526","TRIS PHARMA INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
"DYSPORT","abobotulinumtoxinA","INJECTABLE; INJECTION","125274","IPSEN BIOPHARM LTD","09/21/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30"
"EC-NAPROSYN","NAPROXEN","TABLET, DELAYED RELEASE;ORAL","020067","ATNAHS PHARMA US","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
"EDLUAR","ZOLPIDEM TARTRATE","TABLET;SUBLINGUAL","021997","MYLAN SPECIALITY LP","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23"
"EFFEXOR","VENLAFAXINE HYDROCHLORIDE","TABLET;ORAL","020151","WYETH PHARMS INC","12/12/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34"
"EFFEXOR XR","VENLAFAXINE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","020699","UPJOHN","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41"
"EFFIENT","PRASUGREL HYDROCHLORIDE","TABLET;ORAL","022307","DAIICHI SANKYO INC","12/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21"
"ELEPSIA XR","LEVETIRACETAM","TABLET, EXTENDED RELEASE;ORAL","204417","TRIPOINT","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25"
"ELIDEL","PIMECROLIMUS","CREAM;TOPICAL","021302","BAUSCH","06/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf"
"ELIQUIS","APIXABAN","TABLET;ORAL","202155","BRISTOL MYERS SQUIBB","10/12/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38"
"ELMIRON","PENTOSAN POLYSULFATE SODIUM","CAPSULE;ORAL","020193","JANSSEN PHARMS","03/12/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11"
"ELREXFIO","ELRANATAMAB-BCMM","INJECTABLE; SUBCUTANEOUS","761345","PFIZER","08/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761345s000lbl.pdf#page=22"
"ELUCIREM","GADOPICLENOL","INJECTABLE;INTRAVENOUS","216986","LIEBEL-FLARSHEIM COMPANY","01/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf#page=17"
"ELYXYB","CELECOXIB","SOLUTION;ORAL","212157","BDSI","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26"
"EMBEDA","MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","022321","ALPHARMA PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30"
"EMPAVEL","PEGCETACOPLAN","INJECTABLE;SUBCUTANEOUS","215014","APELLIS PHARMACEUTICALS","02/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215014s003lbl.pdf#page=18"
"EMSAM","SELEGILINE","FILM, EXTENDED RELEASE;TRANSDERMAL","021336","SOMERSET","07/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34"
"ENBREL","ETANERCEPT","VIAL; SUBCUTANEOUS","103795","IMMUNEX","09/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf#page=36"
"ENBREL","ETANERCEPT","SYRINGE","103795","IMMUNEX","06/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103795s5594lbl.pdf#page=35"
"ENHERTU","FAM-TRASTUZUMAB DERUXTECAN-NXKI","INJECTABLE;INJECTION","761139","DAIICHI SANKYO","04/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s022lbl.pdf#page=31"
"ENJAYMO","Sutimlimab-Jome","INJECTABLE;INJECTION","761164","NULL","02/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13"
"ENSPRYNG","SATRALIZUMAB-MWGE","INJECTABLE;SUBCUTANEOUS","761149","GENETECH, INC","09/14/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf#page=16"
"ENTYVIO","VEDOLIZUMAB","INJECTABLE;INTRAVENOUS","761133","TAKEDA PHARMACEUTICALS USA INC","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23"
"ENTYVIO","VEDOLIZUMAB","INJECTABLE;SUBCUTANEOUS","761133","TAKEDA PHARMACEUTICALS USA INC","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23"
"ENTYVIO","VEDOLIZUMAB","INJECTABLE;INJECTION","125476","TAKEDA PHARMS USA","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20"
"ENTYVIO PEN","VEDOLIZUMAB","INJECTABLE;SUBCUTANEOUS","761133","TAKEDA PHARMACEUTICALS USA INC","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23"
"ENVARSUS XR","TACROLIMUS","TABLET, EXTENDED RELEASE;ORAL","206406","VELOXIS PHARMS INC","04/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29"
"EOVIST","GADOXETATE DISODIUM","SOLUTION;INTRAVENOUS","022090","BAYER HLTHCARE","01/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf#page=15"
"EPIDIOLEX","CANNABIDIOL","SOLUTION;ORAL","210365","GW RES LTD","03/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210365s020lbl.pdf#page=31"
"EPKINLY","EPCORITAMAB-BYSP","INJECTABLE;SUBCUTANEOUS","761324","GENMAB US","06/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761324s000lbl.pdf#page=26"
"EPOGEN","EPOETIN ALFA","VIAL; SINGLE-USE","103234","AMGEN","04/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27"
"EPZICOM","ABACAVIR SULFATE; LAMIVUDINE","TABLET;ORAL","021652","VIIV HLTHCARE","12/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28"
"EQUETRO","CARBAMAZEPINE","CAPSULE, EXTENDED RELEASE;ORAL","021710","VALIDUS PHARMS","10/14/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27"
"ERELZI","ETANERCEPT-SZZS","INJECTABLE; INJECTION","761042","SANDOZ","11/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41"
"ERIVEDGE","VISMODEGIB","CAPSULE;ORAL","203388","GENENTECH","03/27/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15"
"ESOMEPRAZOLE STRONTIUM","ESOMEPRAZOLE STRONTIUM","CAPSULE, DELAYED RELEASE;ORAL","202342","BELCHER","03/04/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29"
"ESTAZOLAM","ESTAZOLAM","TABLET;ORAL","074921","MAYNE PHARMA","02/05/2021","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf"
"ETICOVO","ETANERCEPT-YKRO","INJECTABLE;INJECTION","761066","SAMSUNG BIOEPIS CO LTD","05/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31"
"EVEKEO ODT","AMPHETAMINE SULFATE","TABLET, ORALLY DISINTEGRATING;ORAL","209905","ARBOR PHARMS LLC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16"
"EVENITY","ROMOSOZUMAB-AQQG","INJECTABLE;INJECTION","761062","AMGEN INC","12/20/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19"
"EVISTA","RALOXIFENE HYDROCHLORIDE","TABLET; ORAL","022042","LILLY","09/13/2007","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf"
"EVISTA","RALOXIFENE HYDROCHLORIDE","TABLET;ORAL","020815","LILLY","06/27/2018","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf"
"EXALGO","HYDROMORPHONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021217","SPECGX LLC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31"
"EXJADE","DEFERASIROX","TABLET, FOR SUSPENSION;ORAL","021882","NOVARTIS","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28"
"EXTAVIA","INTERFERON BETA-1B","INJECTABLE; SUBCUTANEOUS","125290","NOVARTIS PHARMS","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16"
"FABHALTA","IPTACOPAN","CAPSULE;ORAL","218276","NOVARTIS PHARMACEUTICALS","08/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218276s001lbl.pdf#page=19"
"FACTIVE","GEMIFLOXACIN MESYLATE","TABLET;ORAL","021158","LG CHEM LTD","07/26/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30"
"FARXIGA","DAPAGLIFLOZIN","TABLET;ORAL","202293","ASTRAZENECA AB","06/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53"
"FARYDAK","PANOBINOSTAT LACTATE","CAPSULE;ORAL","205353","SECURA","06/06/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf"
"FELBATOL","FELBAMATE","TABLET;ORAL","020189","MYLAN SPECIALITY LP","08/31/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf"
"FELBATOL","FELBAMATE","SUSPENSION;ORAL","020189","MYLAN SPECIALITY LP","08/31/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf"
"FELDENE","PIROXICAM","CAPSULE;ORAL","018147","PFIZER","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21"
"FENSOLVI KIT","LEUPROLIDE ACETATE","POWDER;SUBCUTANEOUS","213150","TOLMAR","04/22/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s002lbl.pdf#page=15"
"FENTANYL CITRATE","FENTANYL CITRATE","TROCHE/LOZENGE;TRANSMUCOSAL","077312","PAR PHARM","09/07/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf"
"FENTANYL CITRATE","FENTANYL CITRATE","TROCHE/LOZENGE;TRANSMUCOSAL","078907","SPECGX LLC","12/03/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf"
"FENTORA","FENTANYL CITRATE","TABLET;BUCCAL, SUBLINGUAL","021947","CEPHALON","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43"
"FERRIPROX","DEFERIPRONE","TABLET;ORAL","212269","CHIESI","11/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17"
"FERRIPROX","DEFERIPRONE","TABLET;ORAL","021825","CHIESI","11/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17"
"FERRIPROX","DEFERIPRONE","SOLUTION;ORAL","208030","CHIESI","11/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13"
"FETZIMA","LEVOMILNACIPRAN HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","204168","ALLERGAN","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29"
"FILSPARI","SPARSENTAN","TABLET;ORAL","216403","TRAVERE THERAPEUTICS","02/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf#page=22"
"FINTEPLA","FENFLURAMINE HYDROCHLORIDE","SOLUTION;ORAL","212102","ZOGENIX INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s013lbl.pdf#page=30"
"FIORICET W/ CODEINE","ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE","CAPSULE;ORAL","020232","ACTAVIS LABS UT INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44"
"FIORINAL W/CODEINE","ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE","CAPSULE;ORAL","019429","ALLERGAN","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39"
"FIRDAPSE","AMIFAMPRIDINE PHOSPHATE","TABLET;ORAL","208078","CATALYST PHARMS","05/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208078s009lbl.pdf#page=12"
"FLECTOR","DICLOFENAC EPOLAMINE","SYSTEM;TOPICAL","021234","INST BIOCHEM","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24"
"FLOWTUSS","GUAIFENESIN; HYDROCODONE BITARTRATE","SOLUTION;ORAL","022424","BKK PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022424s003lbl.pdf#page=23"
"FLOXIN","OFLOXACIN","TABLET;ORAL","019735","JANSSEN PHARMS","02/25/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf"
"FLUOXETINE HYDROCHLORIDE","FLUOXETINE HYDROCHLORIDE","TABLET;ORAL","202133","ALMATICA","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36"
"FOCALIN","DEXMETHYLPHENIDATE HYDROCHLORIDE","TABLET;ORAL","021278","NOVARTIS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17"
"FOCALIN XR","DEXMETHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","021802","NOVARTIS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf#page=20"
"FORADIL","FORMOTEROL FUMARATE","POWDER;INHALATION","020831","NOVARTIS","03/02/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf"
"FORADIL CERTIHALER","FORMOTEROL FUMARATE","POWDER;INHALATION","021592","NOVARTIS","06/02/2010","https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35"
"FORFIVO XL","BUPROPION HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","022497","ALMATICA","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33"
"FORTEO","TERIPARATIDE","SOLUTION;SUBCUTANEOUS","021318","LILLY","09/07/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16"
"FORTESTA","TESTOSTERONE","GEL, METERED;TRANSDERMAL","021463","ENDO PHARMS","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21"
"FOSAMAX","ALENDRONATE SODIUM","SOLUTION;ORAL","021575","MERCK","11/30/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
"FOSAMAX","ALENDRONATE SODIUM","TABLET;ORAL","020560","MERCK AND CO INC","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
"FOSAMAX PLUS D","ALENDRONATE SODIUM; CHOLECALCIFEROL","TABLET;ORAL","021762","ORGANON","08/16/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf"
"FOSAMAX PLUS D","ALENDRONATE SODIUM; CHOLECALCIFEROL","TABLET;ORAL","021762","ORGANON","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23"
"FOSRENOL","LANTHANUM CARBONATE","POWDER;ORAL","204734","TAKEDA PHARMS USA","08/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12"
"FOSRENOL","LANTHANUM CARBONATE","TABLET, CHEWABLE;ORAL","021468","TAKEDA PHARMS USA","08/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12"
"FYCOMPA","PERAMPANEL","TABLET;ORAL","202834","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24"
"FYCOMPA","PERAMPANEL","SUSPENSION;ORAL","208277","EISAI INC","02/23/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24"
"GABITRIL","TIAGABINE HYDROCHLORIDE","TABLET;ORAL","020646","CEPHALON","08/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf"
"GADAVIST","GADOBUTROL","SOLUTION;INTRAVENOUS","201277","BAYER HLTHCARE","01/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf#page=42"
"GATTEX KIT","TEDUGLUTIDE RECOMBINANT","POWDER;SUBCUTANEOUS","203441","NPS PHARMS INC","09/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf#page=32"
"GILENYA","FINGOLIMOD HYDROCHLORIDE","CAPSULE;ORAL","022527","NOVARTIS","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022527s038lbl.pdf#page=27"
"GIMOTI","METOCLOPRAMIDE HYDROCHLORIDE","SPRAY, METERED;NASAL","209388","EVOKE PHARMA INC","01/14/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17"
"GLOPERBA","COLCHICINE","SOLUTION;ORAL","210942","ROMEG","08/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14"
"GLYXAMBI","EMPAGLIFLOZIN; LINAGLIPTIN","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","10/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206073s036lbl.pdf#page=34"
"GOLYTELY","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS","FOR SOLUTION;ORAL","019011","BRAINTREE","05/14/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9"
"GRALISE","GABAPENTIN","TABLET;ORAL","022544","ALMATICA","04/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21"
"H.P. ACTHAR GEL","REPOSITORY CORTICOTROPIN","INJECTABLE; INJECTION","022432","QUESTCOR PHARMA","10/15/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf"
"HADLIMA","ADALIMUMAB-BWWD","INJECTABLE;INJECTION","761059","SAMSUNG BIOEPIS CO LTD","06/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761059s008lbl.pdf#page=46"
"HALCION","TRIAZOLAM","TABLET;ORAL","017892","PFIZER","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20"
"HALFLYTELY","BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL","021551","BRAINTREE","06/03/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf"
"HEMANGEOL","PROPRANOLOL HYDROCHLORIDE","SOLUTION;ORAL","205410","PIERRE FABRE DERMA","06/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11"
"HEMLIBRA","EMICIZUMAB","INJECTABLE;INJECTION","761083","GENENTECH INC","01/31/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf#page=22"
"HORIZANT","GABAPENTIN ENACARBIL","TABLET, EXTENDED RELEASE;ORAL","022399","ARBOR PHARMS LLC","04/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27"
"HULIO","ADALIMUMAB-FKJP","INJECTABLE;INJECTION","761154","MYLAN PHARMS INC","08/25/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761154s005lbl.pdf#page=57"
"HUMIRA","ADALIMUMAB","SYRINGE","125057","ABBVIE INC","11/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125057s423lbl.pdf#page=57"
"HUMIRA","ADALIMUMAB","VIAL","125057","ABBVIE INC","02/24/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60"
"HYCODAN","HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE","TABLET;ORAL","005213","GENUS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27"
"HYCODAN","HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE","SYRUP;ORAL","005213","GENUS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27"
"HYCOFENIX","HYDROCODONE BITARTRATE;PSEUDOEPHEDRINE HYDROCHLORIDE;GUAIFENESIN","SOLUTION;ORAL","022279","BKK PHARMACEUTICALS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022279s003lbl.pdf#page=26"
"HYDROMORPHONE HYDROCHLORIDE","HYDROMORPHONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","204278","PADAGIS US","03/04/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf"
"HYRIMOZ","ADALIMUMAB-ADAZ","INJECTABLE;INJECTION","761071","SANDOZ INC","06/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761071s016lbl.pdf#page=60"
"HYSINGLA ER","HYDROCODONE BITARTRATE","TABLET, EXTENDED RELEASE;ORAL","206627","PURDUE PHARMA LP","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40"
"IBSRELA","TENAPANOR HYDROCHLORIDE","TABLET;ORAL","211801","ARDELYX INC","04/05/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf#page=14"
"ICLUSIG","PONATINIB HYDROCHLORIDE","TABLET;ORAL","203469","TAKEDA PHARMS USA","03/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf#page=34"
"IDACIO","ADALIMUMAB-AACF","INJECTABLE;SUBCUTANEOUS","761255","FRESENIUS KABI USA","06/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48"
"IDHIFA","ENASIDENIB MESYLATE","TABLET;ORAL","209606","CELGENE CORP","12/21/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209606s006lbl.pdf#page=18"
"ILARIS","CANAKINUMAB","INJECTABLE; SUBCUTANEOUS","125319","NOVARTIS PHARMS","08/25/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24"
"ILUMYA","TILDRAKIZUMAB-ASMN","INJECTABLE;INJECTION","761067","SUN PHARMA GLOBAL","04/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10"
"IMFINZI","DURVALUMAB","INJECTABLE;INJECTION","761069","ASTRAZENECA UK LTD","12/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761069s049lbl.pdf#page=68"
"IMIPRAMINE HYDROCHLORIDE","IMIPRAMINE HYDROCHLORIDE","TABLET;ORAL","087846","SPECGX LLC","06/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
"IMJUDO","TREMELIMUMAB-ACTL","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","761270","ASTRAZENECA","11/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32"
"IMJUDO","TREMELIMUMAB-ACTL","INJECTABLE;INTRAVENOUS","761289","ASTRAZENECA","01/25/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31"
"INCIVEK","TELAPREVIR","TABLET;ORAL","201917","VERTEX PHARMS","03/25/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf"
"INDOCIN","INDOMETHACIN","SUPPOSITORY;RECTAL","017814","EGALET","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf"
"INDOCIN","INDOMETHACIN","SUSPENSION;ORAL","018332","EGALET","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf"
"INDOCIN","INDOMETHACIN","CAPSULE;ORAL","016059","EGALET","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25"
"INDOCIN SR","INDOMETHACIN","CAPSULE, EXTENDED RELEASE;ORAL","018185","EGALET","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26"
"INDOMETHACIN","INDOMETHACIN","CAPSULE;ORAL","018829","CHARTWELL MOLECULES","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18"
"INDOMETHACIN","INDOMETHACIN","CAPSULE;ORAL","018851","HERITAGE","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23"
"INDOMETHACIN","INDOMETHACIN","CAPSULE;ORAL","018858","RISING","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf"
"INFLECTRA","INFLIXIMAB-DYYB","INJECTABLE;INJECTION","125544","CELLTRION INC","06/17/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61"
"INPEFA","SOTAGLIFLOZIN","TABLET; ORAL","216203","LEXICON PHARMACEUTICALS","05/26/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf#page=24"
"INREBIC","FEDRATINIB HYDROCHLORIDE","CAPSULE;ORAL","212327","IMPACT","05/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212327s005lbl.pdf#page=21"
"INTERMEZZO","ZOLPIDEM TARTRATE","TABLET;SUBLINGUAL","022328","PURDUE PHARMA","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20"
"INTRON A","INTERFERON ALFA-2B","VIAL","103132","SCHERING","11/26/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40"
"INVIRASE","SAQUINAVIR MESYLATE","CAPSULE;ORAL","020628","HOFFMANN LA ROCHE","03/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24"
"INVIRASE","SAQUINAVIR MESYLATE","TABLET;ORAL","021785","HOFFMANN-LA ROCHE","09/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25"
"INVOKAMET","CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET;ORAL","204353","JANSSEN PHARMS","08/23/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"
"INVOKAMET XR","CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","205879","JANSSEN PHARMS","08/23/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"
"INVOKANA","CANAGLIFLOZIN","TABLET;ORAL","204042","JANSSEN PHARMS","08/23/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48"
"IXIFI","INFLIXIMAB-QBTX","INJECTABLE;INJECTION","761072","PFIZER INC","12/26/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761072s009lbl.pdf#page=46"
"JADENU","DEFERASIROX","TABLET;ORAL","206910","NOVARTIS PHARMS CORP","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31"
"JADENU SPRINKLE","DEFERASIROX","GRANULE;ORAL","207968","NOVARTIS","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31"
"JANUMET","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","TABLET;ORAL","022044","MERCK SHARP DOHME","06/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf#page=33"
"JANUMET XR","METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","TABLET, EXTENDED RELEASE;ORAL","202270","MERCK SHARP DOHME","06/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34"
"JANUVIA","SITAGLIPTIN PHOSPHATE","TABLET;ORAL","021995","MERCK SHARP DOHME","06/21/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27"
"JARDIANCE","EMPAGLIFLOZIN","TABLET;ORAL","204629","BOEHRINGER INGELHEIM","09/21/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47"
"JEMPERLI","DOSTARLIMAB-GXLY","INJECTABLE;INJECTION","761174","GLAXOSMITHKLINE","08/01/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761174s009lbl.pdf#page=37"
"JEMPERLI","DOSTARLIMAB-GXLY","INJECTABLE;INJECTION","761223","GLAXOSMITHKLINE LLC","08/17/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25"
"JENTADUETO","LINAGLIPTIN; METFORMIN HYDROCHLORIDE","TABLET;ORAL","201281","BOEHRINGER INGELHEIM","06/20/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21"
"JENTADUETO XR","LINAGLIPTIN; METFORMIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","208026","BOEHRINGER INGELHEIM","06/20/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22"
"JESDUVROQ","DAPRODUSTAT","TABLET;ORAL","216951","GLAXOSMITHKLINE","02/01/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23"
"JEUVEAU","PRABOTULINUMTOXINA-XVFS","INJECTABLE;INJECTION","761085","EVOLUS INC","07/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9"
"JORNAY PM","METHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","209311","IRONSHORE PHARMS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf#page=20"
"JUVISYNC","SIMVASTATIN; SITAGLIPTIN PHOSPHATE","TABLET;ORAL","202343","MERCK SHARP DOHME","02/24/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf"
"JUXTAPID","LOMITAPIDE MESYLATE","CAPSULE;ORAL","203858","AMRYT","05/27/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32"
"JYNARQUE","TOLVAPTAN","TABLET;ORAL","204441","OTSUKA","11/25/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18"
"KADIAN","MORPHINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","020616","ALLERGAN","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36"
"KALBITOR","ECALLANTIDE","INJECTABLE; INJECTION","125277","DYAX CORP.","12/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13"
"KALETRA","LOPINAVIR; RITONAVIR","TABLET;ORAL","021906","ABBVIE","10/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53"
"KALETRA","LOPINAVIR; RITONAVIR","CAPSULE;ORAL","021226","ABBVIE","10/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53"
"KALETRA","LOPINAVIR; RITONAVIR","SOLUTION;ORAL","021251","ABBVIE","10/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53"
"KAZANO","ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","TABLET;ORAL","203414","TAKEDA PHARMS USA","07/27/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32"
"KEPPRA","LEVETIRACETAM","TABLET;ORAL","021035","UCB INC","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32"
"KEPPRA","LEVETIRACETAM","SOLUTION;ORAL","021505","UCB INC","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32"
"KEPPRA XR","LEVETIRACETAM","TABLET, EXTENDED RELEASE;ORAL","022285","UCB INC","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26"
"KESIMPTA","OFATUMUMAB","SOLUTION;SUBCUTANEOUS","125326","NOVARTIS","04/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf#page=13"
"KETEK","TELITHROMYCIN","TABLET;ORAL","021144","SANOFI AVENTIS US","11/04/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29"
"KEVZARA","SARILUMAB","INJECTABLE;INJECTION","761037","SANOFI SYNTHELABO","06/10/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31"
"KEYTRUDA","PEMBROLIZUMAB","SOLUTION;INTRAVENOUS","125514","MERCK SHARP DOHME","09/17/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165"
"KHEDEZLA","DESVENLAFAXINE","TABLET, EXTENDED RELEASE;ORAL","204683","OSMOTICA PHARM CORP","09/20/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24"
"KLONOPIN","CLONAZEPAM","TABLET;ORAL","017533","CHEPLAPHARM","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24"
"KOMBIGLYZE XR","METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","200678","ASTRAZENECA AB","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47"
"KONVOMEP","OMEPRAZOLE; SODIUM BICARBONATE","SUSPENSION;ORAL","213593","AZURITY","08/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28"
"KORLYM","MIFEPRISTONE","TABLET;ORAL","202107","CORCEPT THERAP","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20"
"KRYSTEXXA","PEGLOTICASE","INJECTABLE; INJECTION","125293","HORIZON PHARMA","07/07/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18"
"KYNAMRO","MIPOMERSEN SODIUM","SOLUTION;SUBCUTANEOUS","203568","KASTLE THERAPS LLC","03/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf"
"LACOSAMIDE","LACOSAMIDE","SOLUTION;ORAL","204839","AMNEAL PHARMS","10/27/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf"
"LACOSAMIDE","LACOSAMIDE","TABLET;ORAL","204855","ACTAVIS LABS FL INC","10/27/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf"
"LACOSAMIDE","LACOSAMIDE","TABLET;ORAL","204857","AMNEAL PHARMS NY","08/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf"
"LAMICTAL","LAMOTRIGINE","TABLET;ORAL","020241","GLAXOSMITHKLINE LLC","03/31/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
"LAMICTAL CD","LAMOTRIGINE","TABLET, FOR SUSPENSION;ORAL","020764","GLAXOSMITHKLINE LLC","03/31/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
"LAMICTAL ODT","LAMOTRIGINE","TABLET, ORALLY DISINTEGRATING;ORAL","022251","GLAXOSMITHKLINE LLC","03/31/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
"LAMICTAL XR","LAMOTRIGINE","TABLET, EXTENDED RELEASE;ORAL","022115","GLAXOSMITHKLINE LLC","03/31/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51"
"LAMICTAL XR","LAMOTRIGINE","TABLET, EXTENDED RELEASE; ORAL","022509","SMITHKLINE BEECHAM","01/29/2010","https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39"
"LAMISIL","TERBINAFINE HYDROCHLORIDE","TABLET;ORAL","020539","NOVARTIS","03/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11"
"LAMISIL","TERBINAFINE HYDROCHLORIDE","GRANULE;ORAL","022071","NOVARTIS","03/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10"
"LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE","LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE","TABLET;ORAL","205626","MICRO LABS","08/13/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50"
"LARIAM","MEFLOQUINE HYDROCHLORIDE","TABLET;ORAL","019591","ROCHE","04/29/2011","https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13"
"LATUDA","LURASIDONE HYDROCHLORIDE","TABLET;ORAL","200603","SUNOVION PHARMS INC","12/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62"
"LAZANDA","FENTANYL CITRATE","SPRAY, METERED;NASAL","022569","BTCP PHARMA","12/03/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35"
"LEMTRADA","ALEMTUZUMAB","INJECTABLE;INJECTION","103948","GENZYME","05/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30"
"LEQEMBI","ECANEMAB-IRMB","INJECTABLE;INTRAVENOUS","761269","EISAI INC","07/06/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf#page=21"
"LETAIRIS","AMBRISENTAN","TABLET;ORAL","022081","GILEAD","06/08/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26"
"LEVAQUIN","LEVOFLOXACIN","SOLUTION;ORAL","021721","JANSSEN PHARMS","02/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
"LEVAQUIN","LEVOFLOXACIN","TABLET;ORAL","020634","JANSSEN PHARMS","02/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54"
"LEVAQUIN","LEVOFLOXACIN","INJECTABLE;INJECTION","020635","JANSSEN PHARMS","02/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
"LEVAQUIN","LEVOFLOXACIN","INJECTABLE;INJECTION","020635","JANSSEN PHARMS","02/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
"LEXAPRO","ESCITALOPRAM OXALATE","TABLET;ORAL","021323","ALLERGAN","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30"
"LEXAPRO","ESCITALOPRAM OXALATE","SOLUTION;ORAL","021365","ALLERGAN","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30"
"LIBRAX","CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE","CAPSULE;ORAL","012750","BAUSCH","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13"
"LIBRIUM","CHLORDIAZEPOXIDE HYDROCHLORIDE","CAPSULE;ORAL","012249","VALEANT PHARM INTL","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8"
"LIBTAYO","CEMIPLIMAB-RWLC","INJECTABLE;INTRAVENOUS","761097","REGENERON PHARMACEUTICALS","04/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761097s016lbl.pdf#page=36"
"LICART","DICLOFENAC EPOLAMINE","SYSTEM;TOPICAL","206976","IBSA INST BIO","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21"
"LIMBITROL","AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE","TABLET;ORAL","016949","HERITAGE PHARMS INC","02/05/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14"
"LIMBITROL DS","AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE","TABLET;ORAL","016949","HERITAGE PHARMS INC","02/05/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14"
"LINDANE","LINDANE","SHAMPOO;TOPICAL","087266","OLTA PHARMS","04/05/2004","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf"
"LINDANE","LINDANE","LOTION;TOPICAL","087313","OLTA PHARMS","09/04/2001","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf"
"LINZESS","LINACLOTIDE","CAPSULE;ORAL","202811","ALLERGAN","06/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf#page=23"
"LITHIUM CARBONATE","LITHIUM CARBONATE","CAPSULE;ORAL","017812","HIKMA","10/13/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
"LITHIUM CARBONATE","LITHIUM CARBONATE","TABLET;ORAL","018558","HIKMA","10/13/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
"LITHIUM CITRATE","LITHIUM CITRATE","SYRUP;ORAL","018421","HIKMA","10/13/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
"LOQTORZI","TORIPALIMAB-TPZI","INJECTABLE;INTRAVENOUS","761240","COHERUS BIOSCIENCES INC","04/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24"
"LOREEV XR","LORAZEPAM","CAPSULE, EXTENDED RELEASE;ORAL","214826","Almatica Pharma","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16"
"LOTRONEX","ALOSETRON HYDROCHLORIDE","TABLET;ORAL","021107","SEBELA IRELAND LTD","04/03/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf"
"LUMOXITI","MOXETUMOMAB PASUDOTOX-TDFK","INJECTABLE;INJECTION","761104","INNATE PHARMA","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18"
"LUNESTA","ESZOPICLONE","TABLET;ORAL","021476","SUNOVION PHARMS INC","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26"
"LUNSUMIO","MOSUNETUZUMAB-AXGB","INJECTABLE;INTRAVENOUS","761263","GENENTECH, INC","11/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761263s005lbl.pdf#page=19"
"LUPANETA PACK","leuprolide acetate for depot suspension, norethindrone acetate USP","INJECTABLE;INTRAMUSCULAR; TABLET;ORAL","203696","GLENMARK PHARMACEUTICALS","08/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30"
"LUPKYNIS","VOCLOSPORIN","CAPSULE;ORAL","213716","AURINIA","04/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23"
"LUPRON","LEUPROLIDE ACETATE","INJECTABLE;INJECTION","019010","ABBVIE ENDOCRINE INC","12/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27"
"LUPRON DEPOT-PED KIT","LEUPROLIDE ACETATE","POWDER;INTRAMUSCULAR","020263","ABBVIE ENDOCRINE INC","04/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020263s053lbl.pdf#page=26"
"LUVOX","FLUVOXAMINE MALEATE","TABLET;ORAL","021519","ANI PHARMS","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32"
"LUVOX CR","FLUVOXAMINE MALEATE","CAPSULE, EXTENDED RELEASE;ORAL","022033","JAZZ PHARMS","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26"
"LYBALVI","OLANZAPINE; SAMIDORPHAN L-MALATE","TABLET;ORAL","213378","ALKERMES INC","01/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40"
"LYNPARZA","OLAPARIB","CAPSULE;ORAL","206162","ASTRAZENECA","09/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16"
"LYNPARZA","OLAPARIB","TABLET;ORAL","208558","ASTRAZENECA","11/06/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s028lbl.pdf#page=58"
"LYRICA","PREGABALIN","CAPSULE;ORAL","021446","UPJOHN","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57"
"LYRICA","PREGABALIN","SOLUTION;ORAL","022488","UPJOHN","12/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57"
"LYRICA CR","PREGABALIN","TABLET, EXTENDED RELEASE;ORAL","209501","UPJOHN","12/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31"
"MAGNEVIST","GADOPENTETATE DIMEGLUMINE","INJECTABLE;INJECTION","019596","BAYER HLTHCARE","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12"
"MAGNEVIST","GADOPENTETATE DIMEGLUMINE","INJECTABLE;INJECTION","021037","BAYER HLTHCARE","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13"
"MARPLAN","ISOCARBOXAZID","TABLET;ORAL","011961","VALIDUS PHARMS INC","11/08/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16"
"MAVENCLAD","CLADRIBINE","TABLET;ORAL","022561","EMD SERONO INC","09/19/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf#page=29"
"MAYZENT","SIPONIMOD FUMARIC ACID","TABLET;ORAL","209884","NOVARTIS","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209884s016s018lbl.pdf#page=23"
"MEKTOV","BINIMETINIB","TABLET;ORAL","210498","ARRAY BIOPHARMA INC","09/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21"
"MERIDIA","SIBUTRAMINE HYDROCHLORIDE","CAPSULE;ORAL","020632","ABBOTT","08/04/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf"
"METADATE CD","METHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","021259","LANNETT CO INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf#page=16"
"METHYLIN","METHYLPHENIDATE HYDROCHLORIDE","SOLUTION;ORAL","021419","SPECGX LLC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17"
"METHYLIN","METHYLPHENIDATE HYDROCHLORIDE","TABLET, CHEWABLE;ORAL","021475","SPECGX LLC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021475s012lbl.pdf#page=13"
"METOCLOPRAMIDE HYDROCHLORIDE","METOCLOPRAMIDE HYDROCHLORIDE","SOLUTION;ORAL","074703","WOCKHARDT BIO AG","04/08/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf"
"METOZOLV ODT","METOCLOPRAMIDE HYDROCHLORIDE","TABLET, ORALLY DISINTEGRATING;ORAL","022246","SALIX PHARMS","02/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18"
"MIFEPREX","MIFEPRISTONE","TABLET; ORAL","020687","DANCO LABS LLC","03/23/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16"
"MIRCERA","METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA","SOLUTION; INJECTION","125164","HOFFMAN-LA ROCHE","06/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23"
"MIRCERA","METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA","INJECTABLE; SUBCUTANEOUS","126164","Vifor International Inc","04/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27"
"MITIGARE","COLCHICINE","CAPSULE;ORAL","204820","HIKMA AMERICAS","09/26/2014","http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11"
"MITIGARE","COLCHICINE","CAPSULE;ORAL","204820","HIKMA INTL PHARMS","09/26/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf"
"MOBIC","MELOXICAM","TABLET;ORAL","020938","BOEHRINGER INGELHEIM","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16"
"MOBIC","MELOXICAM","SUSPENSION;ORAL","021530","AVONDALE PHARMS","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16"
"MORPHABOND ER","MORPHINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","206544","DAIICHI SANKYO INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38"
"MORPHINE SULFATE","MORPHINE SULFATE","SOLUTION;ORAL","201517","LANNETT CO INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30"
"MORPHINE SULFATE","MORPHINE SULFATE","SOLUTION;ORAL","022195","HIKMA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23"
"MORPHINE SULFATE","MORPHINE SULFATE","TABLET;ORAL","022207","HIKMA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29"
"MOTPOLY XR","LACOSAMIDE","CAPSULE, EXTENDED RELEASE;ORAL","216185","Aucta Pharmaceuticals","06/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22"
"MOTRIN","IBUPROFEN","TABLET;ORAL","017463","MCNEIL CONSUMER","09/10/2007","https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13"
"MOUNJARO","TIRZEPATIDE","INJECTABLE; SUBCUTANEOUS","215866","ELI LILLY AND COMPANY","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s002s006lbl.pdf#page=20"
"MOVANTIK","NALOXEGOL OXALATE","TABLET;ORAL","204760","REDHILL","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16"
"MOVIPREP","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","FOR SOLUTION;ORAL","021881","SALIX PHARMS","05/14/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13"
"MOXIFLOXACIN HYDROCHLORIDE","MOXIFLOXACIN HYDROCHLORIDE","SOLUTION;INTRAVENOUS","205572","FRESENIUS KABI USA","07/26/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49"
"MS CONTIN","MORPHINE SULFATE","TABLET, EXTENDED RELEASE;ORAL","019516","PURDUE PHARMA LP","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf#page=32"
"MULTAQ","DRONEDARONE HYDROCHLORIDE","TABLET;ORAL","022425","SANOFI AVENTIS US","10/23/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24"
"MULTIHANCE","GADOBENATE DIMEGLUMINE","INJECTABLE;INTRAVENOUS","021357","BRACCO","08/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"
"MULTIHANCE MULTIPACK","GADOBENATE DIMEGLUMINE","INJECTABLE;INTRAVENOUS","021358","BRACCO","08/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"
"MYALEPT","METRELEPTIN","INJECTABLE;INJECTION","125390","AEGERION","02/28/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16"
"MYDAYIS","AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE","CAPSULE, EXTENDED RELEASE;ORAL","022063","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25"
"MYFORTIC","MYCOPHENOLIC SODIUM","TABLET, DELAYED RELEASE;ORAL","050791","NOVARTIS","03/15/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf#page=23"
"MYOBLOC","Botulinum Toxin Type B","VIAL","103846","ELAN PHARM","03/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17"
"MYSOLINE","PRIMIDONE","TABLET;ORAL","009170","VALEANT","06/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7"
"NALFON","FENOPROFEN CALCIUM","CAPSULE;ORAL","017604","XSPIRE PHARMA","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16"
"NAPRELAN","NAPROXEN SODIUM","TABLET, EXTENDED RELEASE;ORAL","020353","ALMATICA","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21"
"NAPROSYN","NAPROXEN","SUSPENSION;ORAL","018965","ATNAHS PHARMA US","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22"
"NAPROSYN","NAPROXEN","TABLET;ORAL","017581","ATNAHS PHARMA US","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
"NARDIL","PHENELZINE SULFATE","TABLET;ORAL","011909","PARKE DAVIS","08/02/2007","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf"
"NATPARA","PARATHYROID HORMONE","INJECTABLE;INJECTION","125511","NPS PHARMS INC","07/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18"
"NAYZILAM","MIDAZOLAM","SPRAY;NASAL","211321","UCB INC","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26"
"NESINA","ALOGLIPTIN BENZOATE","TABLET;ORAL","022271","TAKEDA PHARMS USA","07/27/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28"
"NEURONTIN","GABAPENTIN","SOLUTION;ORAL","021129","UPJOHN","12/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
"NEURONTIN","GABAPENTIN","TABLET;ORAL","020882","UPJOHN","12/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
"NEURONTIN","GABAPENTIN","CAPSULE;ORAL","020235","UPJOHN","12/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
"NEXIUM","ESOMEPRAZOLE MAGNESIUM","FOR SUSPENSION, DELAYED RELEASE;ORAL","022101","ASTRAZENECA","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
"NEXIUM","ESOMEPRAZOLE MAGNESIUM","CAPSULE, DELAYED REL PELLETS;ORAL","021153","ASTRAZENECA","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
"NEXIUM","ESOMEPRAZOLE MAGNESIUM","FOR SUSPENSION, DELAYED RELEASE;ORAL","021957","ASTRAZENECA","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
"NIZORAL","KETOCONAZOLE","TABLET;ORAL","018533","JANSSEN PHARMS","07/30/2013","https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19"
"NOCDURNA","DESMOPRESSIN ACETATE","TABLET;SUBLINGUAL","022517","FERRING PHARMS INC","06/21/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14"
"NOCTIVA","DESMOPRESSIN ACETATE","SPRAY, METERED;NASAL","201656","SERENITY PHARMS LLC","03/03/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13"
"NOLVADEX","TAMOXIFEN CITRATE","TABLET;ORAL","017970","ASTRAZENECA","03/13/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf"
"NORCO","ACETAMINOPHEN; HYDROCODONE BITARTRATE","TABLET;ORAL","040099","APIL","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23"
"NOROXIN","NORFLOXACIN","TABLET;ORAL","019384","MERCK","07/26/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf"
"NORPRAMIN","DESIPRAMINE HYDROCHLORIDE","TABLET;ORAL","014399","VALIDUS PHARMS","11/09/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf"
"NOVANTRONE","MITOXANTRONE HYDROCHLORIDE","INJECTABLE;INJECTION","019297","EMD SERONO","03/23/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf"
"NPLATE","ROMIPLOSTIM","INJECTABLE; SUBCUTANEOUS","125268","AMGEN","02/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18"
"NUCYNTA","TAPENTADOL HYDROCHLORIDE","TABLET;ORAL","022304","COLLEGIUM PHARM INC","06/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40"
"NUCYNTA","TAPENTADOL HYDROCHLORIDE","SOLUTION;ORAL","203794","COLLEGIUM PHARM INC","06/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37"
"NUCYNTA ER","TAPENTADOL HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","200533","COLLEGIUM PHARM INC","06/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40"
"NULOJIX","BELATACEPT","INJECTABLE; INJECTION","125288","BRISTOL MYERS SQUIBB","07/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49"
"NULYTELY","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","FOR SOLUTION;ORAL","019797","BRAINTREE","05/14/2021","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"
"NULYTELY-FLAVORED","POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE","FOR SOLUTION;ORAL","019797","BRAINTREE","05/14/2021","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"
"NUVIGIL","ARMODAFINIL","TABLET;ORAL","021875","CEPHALON","02/07/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24"
"OBREDON","GUAIFENESIN; HYDROCODONE BITARTRATE","SOLUTION;ORAL","205474","SOVEREIGN PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23"
"OCALIVA","OBETICHOLIC ACID","TABLET;ORAL","207999","INTERCEPT PHARMS INC","05/26/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22"
"OCREVUS","OCRELIZUMAB","INJECTABLE;INJECTION","761053","GENENTECH INC","06/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761053s031lbl.pdf#page=20"
"OCREVUS ZUNOVO","OCRELIZUMAB AND HYALURONIDAZSE-OCSQ","INJECTABLE;SUBCUTANEOUS","761371","GENETECH, INC.","09/13/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761371s000lbl.pdf#page=21"
"ODOMZO","SONIDEGIB PHOSPHATE","CAPSULE;ORAL","205266","SUN PHARMA GLOBAL","08/22/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14"
"OLEPTRO","TRAZODONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","022411","ANGELINI PHARMA","07/17/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf"
"OLUMIANT","BARICITINIB","TABLET;ORAL","207924","ELI LILLY AND CO","05/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf#page=26"
"OMNISCAN","GADODIAMIDE","INJECTABLE;INJECTION","022066","GE HEALTHCARE","01/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1"
"OMNISCAN","GADODIAMIDE","INJECTABLE;INJECTION","020123","GE HEALTHCARE","01/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1"
"OMONTYS","PEGINESATIDE ACETATE","SOLUTION;INTRAVENOUS, SUBCUTANEOUS","202799","TAKEDA PHARMS USA","12/04/2012","https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15"
"OMVOH","MIRIKIZUMAB-MRKZ","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","761279","ELI LILLY AND COMPANY","04/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf#page=15"
"ONFI","CLOBAZAM","TABLET;ORAL","202067","LUNDBECK PHARMS LLC","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29"
"ONFI","CLOBAZAM","SUSPENSION;ORAL","203993","LUNDBECK PHARMS LLC","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29"
"ONGLYZA","SAXAGLIPTIN HYDROCHLORIDE","TABLET;ORAL","022350","ASTRAZENECA AB","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31"
"ONSOLIS","FENTANYL CITRATE","FILM;BUCCAL","022266","BDSI","12/03/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32"
"OPANA","OXYMORPHONE HYDROCHLORIDE","TABLET;ORAL","021611","ENDO PHARMS","10/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27"
"OPANA ER","OXYMORPHONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021610","ENDO PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32"
"OPANA ER","OXYMORPHONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","201655","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26"
"OPDIVO","NIVOLUMAB","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","10/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125554s127lbl.pdf#page=166"
"OPSUMIT","MACITENTAN","TABLET;ORAL","204410","ACTELION","05/26/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204410s024lbl.pdf#page=20"
"OPTIMARK","GADOVERSETAMIDE","INJECTABLE;INJECTION","020937","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14"
"OPTIMARK","GADOVERSETAMIDE","INJECTABLE;INJECTION","020975","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13"
"OPTIMARK IN PLASTIC CONTAINER","GADOVERSETAMIDE","INJECTABLE;INJECTION","020976","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13"
"OPZELURA","RUXOLITINIB PHOSPHATE","CREAM;TOPICAL","215309","INCYTE CORP","03/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf#page=19"
"ORIAHNN (COPACKAGED)","ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM","CAPSULE;ORAL","213388","ABBVIE INC","05/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29"
"ORILISSA","ELAGOLIX SODIUM","TABLET;ORAL","210450","ABBVIE INC","06/05/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27"
"OSENI","ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE","TABLET;ORAL","022426","TAKEDA PHARMS USA","06/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43"
"OSMOPREP","SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE","TABLET;ORAL","021892","SALIX PHARMS","11/29/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13"
"OTULFI","USTEKINUMAB-AAUZ","INJECTABLE;INTRAVENOUS","761379","FRESENIUS KABI USA","09/27/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761379s000lbl.pdf#page=36"
"OXAYDO","OXYCODONE HYDROCHLORIDE","TABLET;ORAL","202080","ZYLA","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30"
"OXTELLAR XR","OXCARBAZEPINE","TABLET, EXTENDED RELEASE;ORAL","202810","SUPERNUS PHARMS","08/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24"
"OXYCODONE HYDROCHLORIDE","OXYCODONE HYDROCHLORIDE","SOLUTION;ORAL","200535","GENUS LIFESCIENCES","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35"
"OXYCODONE HYDROCHLORIDE","OXYCODONE HYDROCHLORIDE","SOLUTION;ORAL","201194","VISTAPHARM","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34"
"Oxycodone Hydrochloride Capsules","OXYCODONE HYDROCHLORIDE","CAPSULE;ORAL","200534","GENUS LIFESCIENCES","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32"
"OXYCONTIN","OXYCODONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","022272","PURDUE PHARMA LP","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49"
"OXYMORPHONE HYDROCHLORIDE","OXYMORPHONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","079046","ACTAVIS ELIZABETH","03/04/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf"
"OZEMPIC","SEMAGLUTIDE","SOLUTION;SUBCUTANEOUS","209637","NOVO","10/06/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf#page=27"
"PACERONE","AMIODARONE HYDROCHLORIDE","TABLET;ORAL","075135","UPSHER SMITH LABS","11/01/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf"
"PALLADONE","HYDROMORPHONE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","021044","PURDUE PHARMA LP","04/16/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf"
"PALYNZIQ","PEGVALIASE-PQPZ","INJECTABLE;INJECTION","761079","BIOMARIN PHARM","11/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23"
"PAMELOR","NORTRIPTYLINE HYDROCHLORIDE","SOLUTION;ORAL","018012","SPECGX LLC","07/28/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf"
"PAMELOR","NORTRIPTYLINE HYDROCHLORIDE","CAPSULE;ORAL","018013","SPECGX LLC","04/09/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15"
"PANCREAZE","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","CAPSULE, DELAYED RELEASE;ORAL","022523","VIVUS INC","02/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16"
"PARNATE","TRANYLCYPROMINE SULFATE","TABLET;ORAL","012342","CONCORDIA","01/04/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18"
"PAXIL","PAROXETINE HYDROCHLORIDE","SUSPENSION;ORAL","020710","APOTEX TECHNOLOGIES","11/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39"
"PAXIL","PAROXETINE HYDROCHLORIDE","TABLET;ORAL","020031","APOTEX TECHNOLOGIES","11/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39"
"PAXIL CR","PAROXETINE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","020936","APOTEX TECHNOLOGIES","02/23/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30"
"PEGANONE","ETHOTOIN","TABLET;ORAL","010841","RECORDATI RARE","02/27/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf"
"PEGASYS","PEGINTERFERON ALFA-2A","VIAL; SUBCUTANEOUS","103964","HOFFMAN-LA ROCHE","12/11/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37"
"PEGASYS","PEGINTERFERON ALFA-2A","SYRINGE","103964","HOFFMAN-LA ROCHE","12/11/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37"
"PEGINTRON","PEGINTERFERON ALFA-2B","SYRINGE","103949","SCHERING","12/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29"
"PENNSAID","DICLOFENAC SODIUM","SOLUTION;TOPICAL","020947","NUVO PHARMS INC","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf"
"PENNSAID","DICLOFENAC SODIUM","SOLUTION;TOPICAL","204623","HORIZON","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20"
"PERCOCET","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","TABLET;ORAL","040330","VINTAGE PHARMS LLC","03/04/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
"PERCODAN","ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE","TABLET;ORAL","007337","ENDO PHARMS","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/007337s057lbl.pdf"
"PERCODAN","ASPIRIN; OXYCODONE HYDROCHLORIDE","TABLET;ORAL","007337","ENDO PHARMS","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30"
"PERFOROMIST","FORMOTEROL FUMARATE","SOLUTION;INHALATION","022007","MYLAN SPECLT","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19"
"PERTZYE","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","CAPSULE, DELAYED RELEASE;ORAL","022175","DIGESTIVE CARE INC","02/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13"
"PEXEVA","PAROXETINE MESYLATE","TABLET;ORAL","021299","SEBELA IRELAND LTD","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18"
"PHENERGAN VC W/ CODEINE","CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE","SYRUP;ORAL","008306","ANI PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66"
"PHENERGAN W/ CODEINE","CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE","SYRUP;ORAL","008306","ANI PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66"
"PLAVIX","CLOPIDOGREL BISULFATE","TABLET;ORAL","020839","SANOFI AVENTIS US","03/01/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24"
"PLEGRIDY","PEGINTERFERON BETA-1A","INJECTABLE;INJECTION","125499","BIOGEN IDEC INC","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20"
"PLENVU","ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE","FOR SOLUTION;ORAL","209381","SALIX","09/08/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18"
"POMALYST","POMALIDOMIDE","CAPSULE;ORAL","204026","CELGENE","03/24/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204026s031lbl.pdf#page=33"
"PONSTEL","MEFENAMIC ACID","CAPSULE;ORAL","015034","AVION PHARMS","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/015034s046lbl.pdf"
"PONVORY","PONESIMOD","TABLET;ORAL","213498","JANSSEN PHARMS","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30"
"POTIGA","EZOGABINE","TABLET;ORAL","022345","GLAXOSMITHKLINE","05/20/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf"
"PRADAXA","DABIGATRAN ETEXILATE MESYLATE","CAPSULE;ORAL","022512","BOEHRINGER INGELHEIM","11/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022512s047lbl.pdf#page=27"
"PRADAXA","DABIGATRAN ETEXILATE MESYLATE","PELLETS;ORAL","214358","BOEHRINGER INGELHEIM","11/14/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214358s007lbl.pdf#page=14"
"PREPOPIK","CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE","FOR SOLUTION;ORAL","202535","FERRING PHARMS INC","08/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15"
"PRETOMANID","PRETOMANID","TABLET;ORAL","212862","MYLAN IRELAND LTD","11/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27"
"PREVACID","LANSOPRAZOLE","CAPSULE, DELAYED REL PELLETS;ORAL","020406","TAKEDA PHARMS USA","08/08/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45"
"PREVACID","LANSOPRAZOLE","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL","021428","TAKEDA PHARMS USA","08/08/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45"
"PREVACID NAPRAPAC 250 (COPACKAGED)","LANSOPRAZOLE; NAPROXEN","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"PREVACID NAPRAPAC 375 (COPACKAGED)","LANSOPRAZOLE; NAPROXEN","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"PREVACID NAPRAPAC 500 (COPACKAGED)","LANSOPRAZOLE; NAPROXEN","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"PRIFTIN","RIFAPENTINE","TABLET;ORAL","021024","SANOFI AVENTIS US","07/01/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28"
"PRILOSEC","OMEPRAZOLE MAGNESIUM","FOR SUSPENSION, DELAYED RELEASE;ORAL","022056","COVIS","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34"
"PRILOSEC","OMEPRAZOLE","CAPSULE, DELAYED REL PELLETS;ORAL","019810","ASTRAZENECA","12/19/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34"
"PRISTIQ","DESVENLAFAXINE SUCCINATE","TABLET, EXTENDED RELEASE;ORAL","021992","PF PRISM CV","11/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36"
"PROBUPHINE","BUPRENORPHINE HYDROCHLORIDE","IMPLANT;IMPLANTATION","204442","TITAN PHARMS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47"
"PROCRIT","EPOETIN ALFA","VIAL; SINGLE-USE","103234","AMGEN","04/30/2024","https://www.fda.gov/media/73511/download"
"PROHANCE","GADOTERIDOL","INJECTABLE;INJECTION","020131","BRACCO","08/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"
"PROHANCE MULTIPACK","GADOTERIDOL","INJECTABLE;INJECTION","021489","BRACCO","08/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"
"PROLIA","DENOSUMAB","INJECTABLE; SUBCUTANEOUS","125320","AMGEN","01/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf#page=31"
"PROMACTA","ELTROMBOPAG OLAMINE","TABLET;ORAL","022291","NOVARTIS","03/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"
"PROMACTA KIT","ELTROMBOPAG OLAMINE","FOR SUSPENSION;ORAL","207027","NOVARTIS","03/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"
"PROPULSID","CISAPRIDE MONOHYDRATE","TABLET;ORAL","020210","JANSSEN PHARMS","03/06/2000","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf"
"PROPYLTHIOURACIL","PROPYLTHIOURACIL","TABLET;ORAL","006188","DAVA PHARMS INC","09/19/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7"
"PROQUIN XR","CIPROFLOXACIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021744","DEPOMED INC","08/15/2011","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf"
"PROTONIX","PANTOPRAZOLE SODIUM","FOR SUSPENSION, DELAYED RELEASE;ORAL","022020","WYETH PHARMS","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31"
"PROTONIX","PANTOPRAZOLE SODIUM","TABLET, DELAYED RELEASE;ORAL","020987","WYETH PHARMS","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31"
"PROTOPIC","TACROLIMUS","OINTMENT;TOPICAL","050777","LEO PHARMA AS","02/25/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf"
"PROVIGIL","MODAFINIL","TABLET;ORAL","020717","CEPHALON","01/15/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf"
"PROZAC","FLUOXETINE HYDROCHLORIDE","CAPSULE;ORAL","018936","ELI LILLY AND CO","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26"
"PROZAC WEEKLY","FLUOXETINE HYDROCHLORIDE","CAPSULE, DELAYED REL PELLETS;ORAL","021235","LILLY","03/24/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"
"QDOLO","TRAMADOL HYDROCHLORIDE","SOLUTION;ORAL","214044","ATHENA","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28"
"QELBREE","VILOXAZINE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","211964","SUPERNUS PHARMS","04/29/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf#page=21"
"QMIIZ ODT","MELOXICAM","TABLET, ORALLY DISINTEGRATING;ORAL","211210","TERSERA","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37"
"QSYMIA","PHENTERMINE HYDROCHLORIDE; TOPIRAMATE","CAPSULE, EXTENDED RELEASE;ORAL","022580","VIVUS","09/13/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022580s025lbl.pdf#page=43"
"QTERN","DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE","TABLET;ORAL","209091","ASTRAZENECA AB","09/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37"
"QTERNMET XR","DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","210874","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47"
"QUALAQUIN","QUININE SULFATE","CAPSULE;ORAL","021799","SUN PHARM INDUSTRIES","06/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26"
"QUDEXY XR","TOPIRAMATE","CAPSULE, EXTENDED RELEASE;ORAL","205122","UPSHER SMITH LABS","03/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54"
"QUILLICHEW ER","METHYLPHENIDATE HYDROCHLORIDE","TABLET, EXTENDED RELEASE, CHEWABLE;ORAL","207960","NEXTWAVE PHARMS","06/25/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21"
"QUILLIVANT XR","METHYLPHENIDATE HYDROCHLORIDE","FOR SUSPENSION, EXTENDED RELEASE;ORAL","202100","NEXTWAVE","06/25/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21"
"QUVIVIQ","DARIDOREXANT","TABLET; ORAL","214985","IDORSIA PHARMACEUTICALS LTD.","09/30/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24"
"RALDESY","TRAZODONE HYDROCHLORIDE, USP","SOLUTION;ORAL","218637","VALIDUS PHARMACEUTICALS LLC","11/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf#page=12"
"RAPAMUNE","SIROLIMUS","SOLUTION;ORAL","021083","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43"
"RAPAMUNE","SIROLIMUS","TABLET;ORAL","021110","PF PRISM CV","08/09/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43"
"RAVICTI","GLYCEROL PHENYLBUTYRATE","LIQUID;ORAL","203284","HORIZON THERAP","09/03/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27"
"REBETOL","RIBAVIRIN","SOLUTION;ORAL","021546","SCHERING","03/16/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26"
"REBETOL","RIBAVIRIN","CAPSULE;ORAL","020903","MERCK SHARP DOHME","03/16/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26"
"REBIF","INTERFERON BETA-1A","SYRINGE","103780","SERONO INC","07/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16"
"RECLAST","ZOLEDRONIC ACID","INJECTABLE;INTRAVENOUS","021817","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25"
"RECORLEV","LEVOKETOCONAZOLE","TABLET;ORAL","214133","STRONGBRIDGE","08/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3"
"REGLAN","METOCLOPRAMIDE HYDROCHLORIDE","TABLET;ORAL","017854","ANI PHARMS","08/29/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf"
"REGLAN","METOCLOPRAMIDE HYDROCHLORIDE","INJECTABLE;INJECTION","017862","HIKMA","11/18/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf"
"REGLAN ODT","METOCLOPRAMIDE HYDROCHLORIDE","TABLET, ORALLY DISINTEGRATING;ORAL","021793","MEDA PHARMS","11/30/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf"
"REGRANEX","BECAPLERMIN","GEL; TOPICAL","103691","SMITH AND NEPHEW","08/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8"
"RELEXXII","METHYLPHENIDATE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","216117","VERTICAL PHARMACEUTICALS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216117s001lbl.pdf#page=25"
"RELISTOR","METHYLNALTREXONE BROMIDE","SOLUTION;SUBCUTANEOUS","021964","SALIX PHARMS","03/14/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24"
"RELISTOR","METHYLNALTREXONE BROMIDE","TABLET;ORAL","208271","SALIX","03/14/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24"
"REMERON","MIRTAZAPINE","TABLET;ORAL","020415","ORGANON USA INC","11/18/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"
"REMERON SOLTAB","MIRTAZAPINE","TABLET, ORALLY DISINTEGRATING;ORAL","021208","ORGANON USA INC","11/18/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"
"REMICADE","INFLIXIMAB","VIAL","103772","CENTOCOR INC","10/05/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf#page=50"
"RENFLEXIS","INFLIXIMAB-ABDA","INJECTABLE;INJECTION","761054","SAMSUNG BIOEPIS CO LTD","12/26/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761054s021lbl.pdf#page=55"
"RESTORIL","TEMAZEPAM","CAPSULE;ORAL","018163","SPECGX LLC","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17"
"RETACRIT","EPOETIN ALFA-EPBX","INJECTABLE;INJECTION","125545","HOSPIRA INC","06/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31"
"REVLIMID","LENALIDOMIDE","CAPSULE;ORAL","021880","CELGENE","03/24/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48"
"REXULTI","BREXPIPRAZOLE","TABLET;ORAL","205422","OTSUKA","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205422s009lbl.pdf#page=36"
"REYVOW","LASMIDITAN SUCCINATE","TABLET;ORAL","211280","ELI LILLY AND CO","09/15/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15"
"REZIRA","HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE","SOLUTION;ORAL","022442","PERSION","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26"
"RIABNI","RITUXIMAB-ARRX","INJECTABLE;INJECTION","761140","AMGEN INC","06/03/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf#page=41"
"RINVOQ","UPADACITINIB","TABLET, EXTENDED RELEASE;ORAL","211675","ABBVIE INC","04/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211675s019lbl.pdf#page=72"
"RITALIN","METHYLPHENIDATE HYDROCHLORIDE","TABLET;ORAL","010187","NOVARTIS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf#page18"
"RITALIN LA","METHYLPHENIDATE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","021284","NOVARTIS","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf#page18"
"RITALIN-SR","METHYLPHENIDATE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","018029","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13"
"RITUXAN","RITUXIMAB","SOLUTION;INTRAVENOUS","103705","GENENTECH","12/17/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56"
"RITUXAN HYCELA","RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)","SOLUTION;SUBCUTANEOUS","761064","GENENTECH INC","06/10/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28"
"ROXICODONE","OXYCODONE HYDROCHLORIDE","TABLET;ORAL","021011","SPECGX LLC","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30"
"ROXYBOND","OXYCODONE HYDROCHLORIDE","TABLET;ORAL","209777","OHEMO LIFE","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38"
"ROZEREM","RAMELTEON","TABLET;ORAL","021782","TAKEDA PHARMS USA","11/03/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17"
"RUXIENCE","RITUXIMAB-PVVR","INJECTABLE;INJECTION","761103","PFIZER INC","10/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761103s011lbl.pdf#page=42"
"RUZURGI","AMIFAMPRIDINE","TABLET;ORAL","209321","JACOBUS PHARM CO INC","08/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15"
"RYBELSUS","SEMAGLUTIDE","TABLET;ORAL","213051","NOVO","01/24/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf#page=24"
"RYBELSUS","SEMAGLUTIDE","TABLET;ORAL","213182","NOVO NORDISK INC","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23"
"SABRIL","VIGABATRIN","FOR SOLUTION;ORAL","022006","LUNDBECK PHARMS LLC","10/20/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26"
"SABRIL","VIGABATRIN","TABLET;ORAL","020427","LUNDBECK PHARMS LLC","10/20/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26"
"SAMSCA","TOLVAPTAN","TABLET;ORAL","022275","OTSUKA","04/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19"
"SARAFEM","FLUOXETINE HYDROCHLORIDE","TABLET;ORAL","021860","APIL","09/20/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32"
"SAVAYSA","EDOXABAN TOSYLATE","TABLET;ORAL","206316","DAIICHI SANKYO INC","10/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35"
"SAVELLA","MILNACIPRAN HYDROCHLORIDE","TABLET;ORAL","022256","ALLERGAN","05/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022256s028lbl.pdf#page=31"
"SAXENDA","LIRAGLUTIDE RECOMBINANT","SOLUTION;SUBCUTANEOUS","206321","NOVO","04/20/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf#page=30"
"SEGLENTIS","CELECOXIB; TRAMADOL HYDROCHLORIDE","TABLET;ORAL","213426","KOWA PHARMS","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57"
"SEGLUROMET","ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET;ORAL","209806","MERCK SHARP DOHME","09/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209806s010lbl.pdf#page=33"
"SELZENTRY","MARAVIROC","SOLUTION;ORAL","208984","VIIV HLTHCARE","10/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43"
"SELZENTRY","MARAVIROC","TABLET;ORAL","022128","VIIV HLTHCARE","10/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43"
"SEREVENT","SALMETEROL XINAFOATE","POWDER;INHALATION","020692","GLAXOSMITHKLINE","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35"
"SEROQUEL","QUETIAPINE FUMARATE","TABLET;ORAL","020639","ASTRAZENECA","01/31/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf#page=49"
"SEROQUEL XR","QUETIAPINE FUMARATE","TABLET, EXTENDED RELEASE;ORAL","022047","ASTRAZENECA","01/28/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf#page=53"
"SERTRALINE","SERTRALINE HYDROCHLORIDE","CAPSULE;ORAL","215133","ALMATICA PHARMA","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215133s001lbl.pdf#page=27"
"SIGNIFOR","PASIREOTIDE DIASPARTATE","SOLUTION;SUBCUTANEOUS","200677","RECORDATI RARE","01/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15"
"SIKLOS","HYDROXYUREA","TABLET;ORAL","208843","ADDMEDICA SAS","11/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18"
"SILENOR","DOXEPIN HYDROCHLORIDE","TABLET;ORAL","022036","CURRAX","10/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19"
"SILIQ","BRODALUMAB","INJECTABLE;INJECTION","761032","VALEANT LUXEMBOURG","08/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761032s014lbl.pdf#page=14"
"SIMPONI","GOLIMUMAB","INJECTABLE; INJECTION","125289","CENTOCOR ORTHO BIOTECH INC","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38"
"SIMPONI ARIA","GOLIMUMAB","INJECTABLE; INJECTION","125433","JANSSEN BIOTECH","02/01/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34"
"SINEQUAN","DOXEPIN HYDROCHLORIDE","CAPSULE;ORAL","016798","PFIZER","07/14/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf"
"SINGULAIR","MONTELUKAST SODIUM","GRANULE;ORAL","021409","MERCK","02/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25"
"SINGULAIR","MONTELUKAST SODIUM","TABLET;ORAL","020829","MSD MERCK CO","02/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25"
"SINGULAIR","MONTELUKAST SODIUM","TABLET, CHEWABLE;ORAL","020830","MSD MERCK CO","02/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25"
"SIRTURO","BEDAQUILINE FUMARATE","TABLET;ORAL","204384","JANSSEN THERAP","06/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204384s017lbl.pdf#page=27"
"SKYRIZI","RISANKIZUMAB-RZAA","INJECTABLE;SUBCUTANEOUS","761262","ABBVIE INC","06/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s001lbl.pdf#page=30"
"SKYRIZI","RISANKIZUMAB-RZAA","INJECTABLE;INJECTION","761105","ABBVIE INC","06/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf#page=30"
"SODIUM OXYBATE","SODIUM OXYBATE","SOLUTION;ORAL","202090","HIKMA","01/03/2022","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18"
"SOHONOS","PALOVEROTENE","CAPSULE;ORAL","215559","IPSEN BIOPHARMACEUTICALS","08/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20"
"Solaraze","Diclofenac Sodium","GEL;TOPICAL","021005","FOUGERA PHARMS","11/14/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22"
"SOLARAZE","DICLOFENAC SODIUM","GEL;TOPICAL","021005","FOUGERA PHARMS","04/28/2021","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf"
"SOLIQUA 100/33","INSULIN GLARGINE; LIXISENATIDE","SOLUTION;SUBCUTANEOUS","208673","SANOFI-AVENTIS US","09/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf#page=29"
"SOLIRIS","ECULIZUMAB","INJECTABLE; IV (INFUSION)","125166","ALEXION PHARM","06/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40"
"SOLTAMOX","TAMOXIFEN CITRATE","SOLUTION;ORAL","021807","MAYNE PHARMA INC","04/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36"
"SONATA","ZALEPLON","CAPSULE;ORAL","020859","PFIZER","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21"
"SORIATANE","ACITRETIN","CAPSULE;ORAL","019821","STIEFEL LABS INC","02/22/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30"
"SOTRET","ISOTRETINOIN","CAPSULE;ORAL","076041","SUN PHARM INDS LTD","04/12/2012","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf"
"SOTYKTU","DEUCRAVACITINIB","TABLET;ORAL","214958","BRISTOL MYERS SQUIBB","09/09/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf#page=19"
"SPEVIGO","SPESOLIMAB-SBZO","INJECTABLE;INTRAVENOUS","761244","Boehringer Ingelheim Pharmaceuticals, Inc","03/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf#page=11"
"SPRAVATO","ESKETAMINE HYDROCHLORIDE","SPRAY;NASAL","211243","JANSSEN PHARMS","10/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf#page=43"
"SPRITAM","LEVETIRACETAM","TABLET, FOR SUSPENSION;ORAL","207958","APRECIA PHARMS","06/14/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36"
"SPRIX","KETOROLAC TROMETHAMINE","SPRAY, METERED;NASAL","022382","ZYLA","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22"
"STAVZOR","VALPROIC ACID","CAPSULE, DELAYED RELEASE;ORAL","022152","BIONPHARMA INC","11/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022152s009lbl.pdf#page=42"
"STEGLATRO","ERTUGLIFLOZIN","TABLET;ORAL","209803","MERCK SHARP DOHME","09/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209803s007lbl.pdf#page=25"
"STEGLUJAN","ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE","TABLET;ORAL","209805","MERCK SHARP DOHME","09/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209805s016lbl.pdf#page=30"
"STELARA","USTEKINUMAB","INJECTABLE;INJECTION","761044","JANSSEN BIOTECH","03/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761044s009lbl.pdf#page=37"
"STELARA","USTEKINUMAB","INJECTABLE; INJECTION","125261","CENTOCOR ORTHO BIOTECH INC","03/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125261s158,761044s009lbl.pdf#page=36"
"STRATTERA","ATOMOXETINE HYDROCHLORIDE","CAPSULE;ORAL","021411","LILLY","01/06/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf#page=20"
"STRIVERDI RESPIMAT","OLODATEROL HYDROCHLORIDE","SPRAY, METERED;INHALATION","203108","BOEHRINGER INGELHEIM","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf"
"SUBLOCADE","BUPRENORPHINE","SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS","209819","INDIVIOR INC","09/22/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45"
"SUBOXONE","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","FILM;BUCCAL, SUBLINGUAL","022410","INDIVIOR INC","06/17/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35"
"SUBOXONE","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TABLET;SUBLINGUAL","020733","INDIVIOR INC","06/17/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32"
"SUBSYS","FENTANYL","SPRAY;SUBLINGUAL","202788","BTCP PHARMA","12/03/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40"
"SUBUTEX","BUPRENORPHINE HYDROCHLORIDE","TABLET;SUBLINGUAL","020732","INDIVIOR INC","06/17/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29"
"SUCLEAR","MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE","SOLUTION;ORAL","203595","BRAINTREE LABS","08/15/2013","https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13"
"SUFLAVE","POLYETHYLENE GLYCOL 3350; SODIUM SULFATE; POTASSIUM CHLORIDE; MAGNESIUM SULFATE; SODIUM CHLORIDE","SOLUTION;ORAL","215344","BRAINTREE LABORATORIES","06/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14"
"SUNOSI","SOLRIAMFETOL HYDROCHLORIDE","TABLET;ORAL","211230","JAZZ","06/28/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23"
"SUPPRELIN LA","HISTRELIN ACETATE","IMPLANT;SUBCUTANEOUS","022058","ENDO PHARM","04/22/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf#page=20"
"SUPREP BOWEL PREP KIT","MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE","SOLUTION;ORAL","022372","BRAINTREE LABS","08/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13"
"SURMONTIL","TRIMIPRAMINE MALEATE","CAPSULE;ORAL","016792","ODYSSEY PHARMS","09/30/2014","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12"
"SUSTOL","GRANISETRON","INJECTION, EXTENDED RELEASE;SUBCUTANEOUS","022445","HERON THERAPS INC","05/25/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022445s010lbl.pdf#page=17"
"SUTAB","MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE","TABLET;ORAL","213135","BRAINTREE LABS","10/24/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15"
"SUTENT","SUNITINIB MALATE","CAPSULE;ORAL","021938","CPPI CV","08/30/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34"
"SYLATRON","PEGINTERFERON ALFA-2B","VIAL","103949","SCHERING","12/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13"
"SYMBYAX","FLUOXETINE HYDROCHLORIDE; OLANZAPINE","CAPSULE;ORAL","021520","LILLY","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021520s055lbl.pdf#page=42"
"SYMLIN","PRAMLINTIDE ACETATE","INJECTABLE;SUBCUTANEOUS","021332","ASTRAZENECA AB","12/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf"
"SYMPAZAN","CLOBAZAM","FILM;ORAL","210833","AQUESTIVE","03/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26"
"SYMPROIC","NALDEMEDINE TOSYLATE","TABLET;ORAL","208854","BDSI","01/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13"
"SYNALGOS-DC","ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE","CAPSULE;ORAL","011483","SUN PHARM INDUSTRIES","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011483s037lbl.pdf"
"SYNAREL","NAFARELIN ACETATE","SPRAY, METERED;NASAL","019886","PFIZER","01/31/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019886s039lbl.pdf#page=28"
"SYNJARDY","EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET;ORAL","206111","BOEHRINGER INGELHEIM","10/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"
"SYNJARDY XR","EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","208658","BOEHRINGER INGELHEIM","10/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"
"SYNRIBO","OMACETAXINE MEPESUCCINATE","POWDER;SUBCUTANEOUS","203585","TEVA PHARMS INTL","05/12/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18"
"TAFINLAR","DABRAFENIB MESYLATE","CAPSULE;ORAL","202806","NOVARTIS","03/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202806s027lbl.pdf#page=46"
"TAFINLAR","DABRAFENIB","TABLET;ORAL","217514","NOVARTIS PHARMACEUTICALS","03/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217514s000lbl.pdf#page=46"
"TALTZ","IXEKIZUMAB","INJECTABLE;INJECTION","125521","ELI LILLY AND CO","07/27/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21"
"TALVEY","TALQUETAMAB-TGVS","INJECTABLE; SUBCUTANEOUS","761342","JANSSEN BIOTECH","08/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf#page=30"
"TANZEUM","ALBIGLUTIDE","INJECTABLE;INJECTION","125431","GLAXOSMITHKLINE LLC","12/20/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36"
"TARGINIQ","NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","205777","PURDUE PHARMA LP","09/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47"
"TASIGNA","NILOTINIB HYDROCHLORIDE","CAPSULE;ORAL","022068","NOVARTIS","02/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36"
"TAVNEOS","AVACOPAN","CAPSULE;ORAL","214487","CHEMOCENTRYX","06/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17"
"TAZVERIK","TAZEMETOSTAT HYDROBROMIDE","TABLET;ORAL","211723","EPIZYME INC","11/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17"
"TAZVERIK","TAZEMETOSTAT HYDROBROMIDE","TABLET;ORAL","213400","EPIZYME INC","06/18/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17"
"TECENTRIQ","ATEZOLIZUMAB","INJECTABLE;INJECTION","761034","GENENTECH INC","04/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761034s049s051lbl.pdf#page=62"
"TECENTRIQ","ATEZOLIZUMAB","INJECTABLE; INJECTION","761041","GENENTECH INC","10/18/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22"
"TECHNIVIE","OMBITASVIR; PARITAPREVIR; RITONAVIR","TABLET;ORAL","207931","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39"
"TECVAYLI","TECLISTAMAB-CQYV","INJECTABLE; SUBCUTANEOUS","761291","JANSSEN BIOTECH","11/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761291s009lbl.pdf#page=28"
"TEGRETOL","CARBAMAZEPINE","SUSPENSION;ORAL","018927","NOVARTIS","09/13/2023","http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19"
"TEGRETOL","CARBAMAZEPINE","TABLET, CHEWABLE;ORAL","018281","NOVARTIS","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"
"TEGRETOL","CARBAMAZEPINE","TABLET;ORAL","016608","NOVARTIS","09/13/2023","http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19"
"TEGRETOL-XR","CARBAMAZEPINE","TABLET, EXTENDED RELEASE;ORAL","020234","NOVARTIS","09/13/2023","http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19"
"TEGSEDI","INOTERSEN SODIUM","SOLUTION;SUBCUTANEOUS","211172","AKCEA THERAPS","01/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28"
"TESTIM","TESTOSTERONE","GEL;TRANSDERMAL","021454","AUXILIUM PHARMS LLC","08/20/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21"
"TESTOSTERONE","TESTOSTERONE","GEL;TRANSDERMAL","202763","ANI PHARMS","10/25/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf"
"TESTOSTERONE CYPIONATE INJECTION","TESTOSTERONE CYPIONATE","INJECTABLE;INTRAMUSCULAR","216318","SLAYBACK PHARMA LLC","02/01/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216318Orig1s002lbl.pdf#page=14"
"THALOMID","THALIDOMIDE","CAPSULE;ORAL","020785","CELGENE","03/24/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020785s071lbl.pdf#page=21"
"TIBSOVO","IVOSIDENIB","TABLET;ORAL","211192","SERVIER","10/24/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38"
"TIKOSYN","DOFETILIDE","CAPSULE;ORAL","020931","PFIZER","08/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27"
"TIVDAK","TISOTUMAB VEDOTIN-TFTV","INJECTABLE;INJECTION","761208","SEAGEN","04/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761208s005lbl.pdf#page=21"
"TIVORBEX","INDOMETHACIN","CAPSULE;ORAL","204768","GENUS","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25"
"TOFIDENCE","TOCILIZUMAB-BAVI","INJECTABLE;INTRAVENOUS","761354","BIOGEN MA","12/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55"
"TOFRANIL","IMIPRAMINE HYDROCHLORIDE","TABLET;ORAL","087846","SPECGX LLC","06/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
"TOFRANIL-PM","IMIPRAMINE PAMOATE","CAPSULE;ORAL","017090","SPECGX LLC","07/28/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf"
"TOLECTIN","TOLMETIN SODIUM","TABLET;ORAL","017628","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"TOLECTIN 600","TOLMETIN SODIUM","TABLET;ORAL","017628","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"TOLECTIN DS","TOLMETIN SODIUM","CAPSULE;ORAL","018084","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"TOPAMAX","TOPIRAMATE","TABLET;ORAL","020505","JANSSEN PHARMS","05/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
"TOPAMAX","TOPIRAMATE","CAPSULE;ORAL","020844","JANSSEN PHARMS","05/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
"TOPAMAX SPRINKLE","TOPIRAMATE","CAPSULE;ORAL","020844","JANSSEN PHARMS","05/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
"TORADOL","KETOROLAC TROMETHAMINE","TABLET;ORAL","019645","ROCHE PALO","03/26/2013","https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23"
"TRACLEER","BOSENTAN","TABLET;ORAL","021290","ACTELION","02/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
"TRACLEER","BOSENTAN","TABLET, FOR SUSPENSION;ORAL","209279","ACTELION","02/08/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
"TRADJENTA","LINAGLIPTIN","TABLET;ORAL","201280","BOEHRINGER INGELHEIM","06/20/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16"
"TRANXENE","CLORAZEPATE DIPOTASSIUM","CAPSULE;ORAL","017105","RECORDATI RARE","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14"
"TRANXENE","CLORAZEPATE DIPOTASSIUM","TABLET;ORAL","017105","RECORDATI RARE","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14"
"TRANXENE SD","CLORAZEPATE DIPOTASSIUM","TABLET;ORAL","017105","RECORDATI RARE","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14"
"TRAZODONE HYDROCHLORIDE","TRAZODONE HYDROCHLORIDE","TABLET;ORAL","071196","APOTEX INC","04/20/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3"
"TRELEGY ELLIPTA","FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE","POWDER;INHALATION","209482","GLAXOSMITHKLINE","06/02/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33"
"TREMFYA","GUSELKUMAB","INJECTABLE;INJECTION","761061","JANSSEN BIOTECH","06/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15"
"TREXIMET","NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE","TABLET;ORAL","021926","CURRAX","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32"
"TRIDIONE","TRIMETHADIONE","SOLUTION;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"TRIDIONE","TRIMETHADIONE","CAPSULE;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"TRIDIONE","TRIMETHADIONE","TABLET;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"TRIJARDY XR","EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","212614","BOEHRINGER INGELHEIM","10/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf#page=44"
"TRILEPTAL","OXCARBAZEPINE","SUSPENSION;ORAL","021285","NOVARTIS","01/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
"TRILEPTAL","OXCARBAZEPINE","TABLET;ORAL","021014","NOVARTIS","01/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
"TRINTELLIX","VORTIOXETINE HYDROBROMIDE","TABLET;ORAL","204447","TAKEDA PHARMS USA","08/23/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33"
"TRIPTODUR KIT","TRIPTORELIN PAMOATE","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","208956","ARBOR PHARMS LLC","12/07/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s010lbl.pdf#page=12"
"TRIUMEQ","ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE","TABLET;ORAL","205551","VIIV HLTHCARE","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"
"TRIUMEQ PD","ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE","SUSPENSION;ORAL","215413","VIIV HLTHCARE","04/18/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"
"TRIZIVIR","ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE","TABLET;ORAL","021205","VIIV HLTHCARE","02/17/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34"
"TROKENDI XR","TOPIRAMATE","CAPSULE, EXTENDED RELEASE;ORAL","201635","SUPERNUS PHARMS","01/04/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf#page=52"
"TROXYCA ER","NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE","CAPSULE, EXTENDED RELEASE;ORAL","207621","PFIZER","05/26/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32"
"TRUDHESA","DIHYDROERGOTAMINE MESYLATE","SPRAY, METERED;NASAL","213436","IMPEL NEUROPHARMA","09/02/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22"
"TRULANCE","PLECANATIDE","TABLET;ORAL","208745","SALIX","04/13/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15"
"TRULICITY","DULAGLUTIDE","INJECTABLE;INJECTION","125469","ELI LILLY AND CO","11/17/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf#page=16"
"TRUVADA","EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE","TABLET;ORAL","021752","GILEAD","04/29/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35"
"TRUXIMA","RITUXIMAB-ABBS","INJECTABLE;INJECTION","761088","CELLTRION INC","02/04/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf#page=49"
"TURALIO","PEXIDARTINIB HYDROCHLORIDE","CAPSULE;ORAL","211810","DAIICHI SANKYO INC","11/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf#page=20"
"TUSSIONEX PENNKINETIC","CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX","SUSPENSION, EXTENDED RELEASE;ORAL","019111","UCB INC","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25"
"TUXARIN ER","CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE","TABLET, EXTENDED RELEASE;ORAL","206323","MAINPOINTE","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206323s008lbl.pdf#page=27"
"TUZISTRA XR","CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX","SUSPENSION, EXTENDED RELEASE;ORAL","207768","AYTU","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27"
"TYENNE","TOCILIZUMAB--AAZG","INJECTABLE;SUBCUTANEOUS","761275","FRESENIUS KABI USA LLC","12/03/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761275s011lbl.pdf#page=46"
"TYMLOS","ABALOPARATIDE","SOLUTION;SUBCUTANEOUS","208743","RADIUS HEALTH INC","12/21/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18"
"TYSABRI","NATALIZUMAB","VIAL; SINGLE-USE","125104","BIOGEN IDEC","10/30/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32"
"TYZEKA","TELBIVUDINE","TABLET;ORAL","022011","NOVARTIS","12/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
"TYZEKA","TELBIVUDINE","SOLUTION;ORAL","022154","NOVARTIS","12/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
"UKONIQ","UMBRALISIB TOSYLATE","TABLET;ORAL","213176","TG THERAPS","02/05/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19"
"ULORIC","FEBUXOSTAT","TABLET;ORAL","021856","TAKEDA PHARMS USA","04/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19"
"ULTOMIRIS","RAVULIZUMAB-CWVZ","INJECTABLE;INJECTION","761108","ALEXION PHARM","06/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41"
"ULTRACET","ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE","TABLET;ORAL","021123","JANSSEN PHARMS","02/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46"
"ULTRAM","TRAMADOL HYDROCHLORIDE","TABLET;ORAL","020281","JANSSEN PHARMS","02/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42"
"ULTRAM ER","TRAMADOL HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021692","VALEANT PHARMS","08/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36"
"UPLIZNA","INEBILIZUMAB-CDON","INJECTABLE;INJECTION","761142","VIELA BIO","06/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17"
"VALCHLOR","MECHLORETHAMINE HYDROCHLORIDE","GEL;TOPICAL","202317","HELSINN","05/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10"
"VALIUM","DIAZEPAM","TABLET;ORAL","013263","ROCHE","03/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s100lbl.pdf#page=19"
"VALTOCO","DIAZEPAM","SPRAY;NASAL","211635","NEURELIS INC","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24"
"VANFLYTA","QUIZARTINIB","TABLET;ORAL","216993","DAIICHI SANKYO","06/25/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20"
"VANTRELA ER","HYDROCODONE BITARTRATE","TABLET, EXTENDED RELEASE;ORAL","207975","TEVA BRANDED PHARM","05/26/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39"
"VELSIPITY","ETRASIMOD ARGANINE","TABLET;ORAL","216956","PFIZER LABS","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24"
"VENBYSI XR","VENLAFAXINE BESYLATE","TABLET, EXTENDED RELEASE; ORAL","215429","ALMATICA","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33"
"VENCLEXTA","VENETOCLAX","TABLET;ORAL","208573","ABBVIE INC","06/15/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208573s026lbl.pdf#page=54"
"VENLAFAXINE HYDROCHLORIDE","VENLAFAXINE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","022104","OSMOTICA PHARM","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35"
"VEOPOZ","POZELIMAB-BBFG","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","761339","REGENERON PHARMACEUTICALS","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16"
"VERQUVO","VERICIGUAT","TABLET;ORAL","214377","Bayer AG","05/10/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16"
"VIBATIV","TELAVANCIN","INJECTABLE; INJECTION","022407","THERAVANCE INC","06/21/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"
"VIBATIV","TELAVANCIN HYDROCHLORIDE","POWDER;INTRAVENOUS","022110","CUMBERLAND PHARMS","07/07/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"
"VIBERZI","ELUXADOLINE","TABLET;ORAL","206940","ALLERGAN HOLDINGS","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20"
"VICOPROFEN","HYDROCODONE BITARTRATE; IBUPROFEN","TABLET;ORAL","020716","ABBVIE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36"
"VICTOZA","LIRAGLUTIDE RECOMBINANT","SOLUTION;SUBCUTANEOUS","022341","NOVO NORDISK INC","07/05/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022341s039lbl.pdf#page=31"
"VICTRELIS","BOCEPREVIR","CAPSULE;ORAL","202258","MERCK SHARP DOHME","01/30/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27"
"VIDEX","DIDANOSINE","FOR SOLUTION;ORAL","020156","BRISTOL-MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34"
"VIDEX EC","DIDANOSINE","CAPSULE, DELAYED REL PELLETS;ORAL","021183","BRISTOL MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33"
"VIEKIRA PAK (COPACKAGED)","DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR","TABLET;ORAL","206619","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49"
"VIEKIRA XR","DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR","TABLET, EXTENDED RELEASE;ORAL","208624","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49"
"VIIBRYD","VILAZODONE HYDROCHLORIDE","TABLET;ORAL","022567","ALLERGAN","04/19/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17"
"VIMOVO","ESOMEPRAZOLE MAGNESIUM; NAPROXEN","TABLET, DELAYED RELEASE;ORAL","022511","HORIZON","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40"
"VIMPAT","LACOSAMIDE","TABLET;ORAL","022253","UCB INC","10/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
"VIMPAT","LACOSAMIDE","SOLUTION;INTRAVENOUS","022254","UCB INC","10/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
"VIMPAT","LACOSAMIDE","SOLUTION;ORAL","022255","UCB INC","10/16/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
"VIOKACE","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","TABLET;ORAL","022542","VIOKACE","02/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12"
"VIRAMUNE","NEVIRAPINE","SUSPENSION;ORAL","020933","BOEHRINGER INGELHEIM","06/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19"
"VIRAMUNE","NEVIRAPINE","TABLET;ORAL","020636","BOEHRINGER INGELHEIM","06/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19"
"VIRAMUNE XR","NEVIRAPINE","TABLET, EXTENDED RELEASE;ORAL","201152","BOEHRINGER INGELHEIM","06/10/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18"
"VISICOL","SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE","TABLET;ORAL","021097","SALIX PHARMS","03/07/2013","https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11"
"VITUZ","CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE","SOLUTION;ORAL","204307","PERSION","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25"
"VIVACTIL","PROTRIPTYLINE HYDROCHLORIDE","TABLET;ORAL","016012","TEVA WOMENS","07/17/2014","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf"
"VIVITROL","NALTREXONE","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","021897","ALKERMES","09/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33"
"VIVLODEX","MELOXICAM","CAPSULE;ORAL","207233","ZYLA","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24"
"VOGELXO","TESTOSTERONE","GEL;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23"
"VOGELXO","TESTOSTERONE","GEL, METERED;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23"
"VOLTAREN","DICLOFENAC SODIUM","TABLET, DELAYED RELEASE;ORAL","019201","NOVARTIS","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18"
"VOLTAREN ARTHRITIS PAIN","DICLOFENAC SODIUM","GEL;TOPICAL","022122","GLAXOSMITHKLINE CONS","11/29/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22"
"VOLTAREN-XR","DICLOFENAC SODIUM","TABLET, EXTENDED RELEASE;ORAL","020254","NOVARTIS","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18"
"VOTRIENT","PAZOPANIB HYDROCHLORIDE","TABLET;ORAL","022465","NOVARTIS","01/25/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27"
"VRAYLAR","CARIPRAZINE HYDROCHLORIDE","CAPSULE;ORAL","204370","ALLERGAN","11/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46"
"VYVANSE","LISDEXAMFETAMINE DIMESYLATE","CAPSULE;ORAL","021977","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38"
"VYVANSE","LISDEXAMFETAMINE DIMESYLATE","TABLET, CHEWABLE;ORAL","208510","TAKEDA PHARMS USA","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38"
"WEGOVY","SEMAGLUTIDE","SOLUTION;SUBCUTANEOUS","215256","NOVO","11/27/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf#page=35"
"WELIREG","BELZUTIFAN","TABLET;ORAL","215383","MERCK SHARP DOHME","02/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215383s006lbl.pdf#page=17"
"WELLBUTRIN","BUPROPION HYDROCHLORIDE","TABLET;ORAL","018644","GLAXOSMITHKLINE","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32"
"WELLBUTRIN SR","BUPROPION HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","020358","GLAXOSMITHKLINE","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34"
"WELLBUTRIN XL","BUPROPION HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","021515","BAUSCH","05/07/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf#page=29"
"WEZLANA","USTEKINUMAB-AUUB","INJECTABLE;SUBCUTANEOUS, INTRAVENOUS","761331","AMGEN INC","10/31/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36"
"WEZLANA","USTEKINUMAB-AUUB","INJECTABLE;SUBCUTANEOUS, INTRAVENOUS","761285","AMGEN INC","10/31/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36"
"XALKORI","CRIZOTINIB","CAPSULE;ORAL","202570","PF PRISM CV","09/07/2023","http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46"
"XANAX","ALPRAZOLAM","TABLET;ORAL","018276","UPJOHN","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22"
"XANAX XR","ALPRAZOLAM","TABLET, EXTENDED RELEASE;ORAL","021434","UPJOHN","01/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23"
"XARELTO","RIVAROXABAN","FOR SUSPENSION;ORAL","215859","JANSSEN PHARMS","02/08/2023","http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf#page=77"
"XARELTO","RIVAROXABAN","TABLET;ORAL","202439","JANSSEN PHARMS","03/01/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77"
"XARELTO","RIVAROXABAN","TABLET;ORAL","022406","JANSSEN PHARMS","02/08/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77"
"XARTEMIS XR","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","204031","MALLINCKRODT INC","09/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34"
"XCOPRI","CENOBAMATE","TABLET;ORAL","212839","SK LIFE","04/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf#page=25"
"XELJANZ","TOFACITINIB CITRATE","SOLUTION;ORAL","213082","PFIZER","09/27/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
"XELJANZ","TOFACITINIB CITRATE","TABLET;ORAL","203214","PF PRISM CV","09/27/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
"XELJANZ XR","TOFACITINIB CITRATE","TABLET, EXTENDED RELEASE;ORAL","208246","PFIZER","09/27/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
"XELSTRYM","DEXTROAMPHETAMINE","SYSTEM;TRANSDERMAL","215401","NOVEN PHARMACEUTICALS INC","10/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215401s008lbl.pdf#page=28"
"XENAZINE","TETRABENAZINE","TABLET;ORAL","021894","BAUSCH","09/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24"
"Xeomin","incobotulinumtoxinA","INJECTABLE;INJECTION","125360","MERZ PHARMS","09/08/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23"
"XIAFLEX","COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","SOLUTION; INJECTION","125338","AUXILIUM PHARMS","07/12/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33"
"XIGDUO XR","DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","205649","ASTRAZENECA AB","06/12/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf#page=59"
"XOLAIR","OMALIZUMAB","VIAL","103976","GENENTECH","02/16/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf#page=37"
"XOSPATA","GILTERITINIB FUMARATE","TABLET;ORAL","211349","ASTELLAS","01/12/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18"
"XPOVIO","SELINEXOR","TABLET;ORAL","212306","KARYOPHARM THERAPS","07/15/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s010lbl.pdf#page=31"
"XTAMPZA ER","OXYCODONE","CAPSULE, EXTENDED RELEASE;ORAL","208090","COLLEGIUM PHARM INC","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40"
"XTRELUS","HYDROCODONE BITARTRATE;GUAIFENESIN","TABLET;ORAL","208085","ECI PHARMACEUTICALS","12/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22"
"XULTOPHY 100/3.6","INSULIN DEGLUDEC; LIRAGLUTIDE","SOLUTION;SUBCUTANEOUS","208583","NOVO","07/10/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208583s021lbl.pdf#page=42"
"XYOSTED (AUTOINJECTOR)","TESTOSTERONE ENANTHATE","SOLUTION;SUBCUTANEOUS","209863","ANTARES PHARMA INC","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16"
"XYREM","SODIUM OXYBATE","SOLUTION;ORAL","021196","JAZZ PHARMS","05/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26"
"XYWAV","CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE","SOLUTION;ORAL","212690","JAZZ","05/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29"
"YERVOY","IPILIMUMAB","INJECTABLE; INJECTION","125377","BRISTOL MYERS SQUIBB","02/15/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125377s129lbl.pdf#page=72"
"YESINTEK","USTEKINUMAB-KFCE","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","761406","BIOCON BIOLOGICS INC","Invalid date","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37"
"YOSPRALA","ASPIRIN; OMEPRAZOLE","TABLET, DELAYED RELEASE;ORAL","205103","GENUS LIFESCIENCES","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29"
"YUFLYMA","ADALIMUMAB-AATY","INJECTABLE;SUBCUTANEOUS","761219","CELLTRION","08/16/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761219s011lbl.pdf#page=43"
"YUSIMRY","ADALIMUMAB-AQVH","INJECTABLE;INJECTION","761216","COHERUS BIOSCIENCES INC","09/13/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf#page=56"
"ZARONTIN","ETHOSUXIMIDE","CAPSULE;ORAL","012380","PARKE DAVIS","10/28/2021","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf"
"ZEGERID","OMEPRAZOLE; SODIUM BICARBONATE","FOR SUSPENSION;ORAL","021636","SALIX","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31"
"ZEGERID","OMEPRAZOLE; SODIUM BICARBONATE","CAPSULE;ORAL","021849","SALIX","07/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31"
"ZELBORAF","VEMURAFENIB","TABLET;ORAL","202429","HOFFMANN LA ROCHE","05/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21"
"ZENPEP","PANCRELIPASE;LIPASE;PROTEASE;AMYLASE","CAPSULE, DELAYED RELEASE;ORAL","022210","AIMMUNE","02/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14"
"ZENPEP","PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)","CAPSULE, DELAYED RELEASE;ORAL","022210","ZENPEP","02/28/2024","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf"
"ZEPOSIA","OZANIMOD HYDROCHLORIDE","CAPSULE;ORAL","209899","CELGENE INTL","06/05/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25"
"ZERIT","STAVUDINE","FOR SOLUTION;ORAL","020413","BRISTOL-MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29"
"ZIAGEN","ABACAVIR SULFATE","SOLUTION;ORAL","020978","VIIV HLTHCARE","11/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27"
"ZILBRYSQ","ZILUCOPLAN","INJECTABLE;SUBCUTANEOUS","216834","UCB INC","04/26/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf#page=20"
"ZINBRYTA","DACLIZUMAB","INJECTABLE;INJECTION","761029","BIOGEN","11/01/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24"
"ZIPSOR","DICLOFENAC POTASSIUM","CAPSULE;ORAL","022202","ASSERTIO","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24"
"ZITUVIMET","SITAGLIPTIN, METFORMIN HYDROCHLORIDE","TABLET;ORAL","216743","ZYDUS PHARMACEUTICALS","11/03/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf#page=38"
"ZITUVIO","SITAGLIPTIN","TABLET;ORAL","211566","ZYDUS PHARMACEUTICALS INC","10/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33"
"ZOHYDRO ER","HYDROCODONE BITARTRATE","CAPSULE, EXTENDED RELEASE;ORAL","202880","RECRO GAINESVILLE","03/04/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30"
"ZOLOFT","SERTRALINE HYDROCHLORIDE","CONCENTRATE;ORAL","020990","UPJOHN","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37"
"ZOLOFT","SERTRALINE HYDROCHLORIDE","TABLET;ORAL","019839","UPJOHN","08/18/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37"
"ZOLPIDEM TARTRATE","ZOLPIDEM TARTRATE","TABLET;ORAL","076062","STRIDES PHARMA","03/07/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf"
"ZOLPIDEM TARTRATE CAPSULES","ZOLPIDEM TARTRATE","CAPSULE;ORAL","215721","Almatica Pharma","05/09/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27"
"ZOLPIMIST","ZOLPIDEM TARTRATE","SPRAY, METERED;ORAL","022196","AYTU","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19"
"ZONEGRAN","ZONISAMIDE","CAPSULE;ORAL","020789","CONCORDIA","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25"
"ZONISADE","ZONISAMIDE","SUSPENSION;ORAL","214273","AZURITY","07/15/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27"
"ZONTIVITY","VORAPAXAR SULFATE","TABLET;ORAL","204886","XSPIRE PHARMA","11/07/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf"
"ZORTRESS","EVEROLIMUS","TABLET;ORAL","021560","NOVARTIS","02/28/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31"
"ZORVOLEX","DICLOFENAC","CAPSULE;ORAL","204592","ZYLA","11/21/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26"
"ZTALMY","GANAXOLONE","SUSPENSION;ORAL","215904","MARINUS PHARMACEUTICALS","06/21/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215904s003s004lbl.pdf#page=16"
"ZUBSOLV","BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","TABLET;SUBLINGUAL","204242","OREXO US INC","03/20/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19"
"ZULRESSO","BREXANOLONE","SOLUTION;INTRAVENOUS","211371","SAGE THERAP","10/17/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20"
"ZURAMPIC","LESINURAD","TABLET;ORAL","207988","IRONWOOD PHARMS INC","08/04/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17"
"ZURZUVAE","ZURANOLONE","CAPSULE;ORAL","217369","BIOGEN INC","08/04/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22"
"ZUTRIPRO","CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE","SOLUTION;ORAL","022439","PERSION","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28"
"ZYBAN","BUPROPION HYDROCHLORIDE","TABLET, EXTENDED RELEASE;ORAL","020711","GLAXOSMITHKLINE","03/09/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38"
"ZYDELIG","IDELALISIB","TABLET;ORAL","205858","GILEAD SCIENCES INC","07/06/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25"
"ZYMFENTRA","INFLIXIMAB-DYYB","INJECTABLE;SUBCUTANEOUS","761358","CELLTRION USA","02/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30"
"ZYNYZ","RETIFANLIMAB-DLWR","INJECTABLE;INTRAVENOUS","761334","INCYTE","04/22/2024","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf#page=18"
"ZYPREXA","OLANZAPINE","TABLET;ORAL","020592","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
"ZYPREXA","OLANZAPINE","INJECTABLE;INTRAMUSCULAR","021253","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
"ZYPREXA RELPREVV","OLANZAPINE PAMOATE","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","022173","ELI LILLY CO","04/28/2021","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29"
"ZYPREXA ZYDIS","OLANZAPINE","TABLET, ORALLY DISINTEGRATING;ORAL","021086","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"